Glaucoma secondary to other eye disorders

H7_GLAUCSECDISEASE

open-angle glaucoma: Chronic outflow obstruction of the eye's drainage canals that can lead to increased internal eye pressure and optic nerve damage.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H40.5 Hospital discharge: ICD-9 — 3655\|3656A Cause of death: ICD-10 — H40.5 Cause of death: ICD-9 — 3655\|3656A 2 out of 7 registries used, show all original rules.	1889
4. Check minimum number of events None	1889
5. Include endpoints None	1889
6. Filter based on genotype QC (FinnGen only)	1659

Control definitions (FinnGen only)

Control exclude: H7_GLAUCOMA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H40
Name in latin: Glaucoma [secundarium] post aliam morbositatem oculi

NAME	H7_GLAUCSECDISEASE
CONTROL_EXCLUDE	H7_GLAUCOMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H405
HD_ICD_9	3655\|3656A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H405
COD_ICD_9	3655\|3656A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Glaucoma secondary to other eye disorders based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Neovascular glaucoma

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1659	769	890
Unadjusted period prevalence (%)	0.35	0.27	0.41
Median age at first event (years)	65.23	62.26	67.79

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1729: Matched controls
17290

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Z01.0

ICD-10 Finland

Examination of eyes and vision

6.7

319.5

722

1676

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

29.8

317.6

215

CKC20

NOMESCO Finland

Cryopexy of undetached retina

99.2

312.1

162

H26.2

ICD-10 Finland

Complicated cataract

35.3

307.7

225

S01EC03

ATC

dorzolamide; ophthalmic

144.5

307.7

279

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

25.5

307.7

334

161

WX140

NOMESCO Finland

Parabulbar anesthesy

24.5

307.7

579

348

H43.1

ICD-10 Finland

Vitreous haemorrhage

24.1

307.7

303

151

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

11.8

307.7

580

712

XCK10

NOMESCO Finland

Photography of fundus of eye

8.9

307.7

535

833

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

9.9

307.7

1325

4307

S01EE04

ATC

travoprost; ophthalmic

72.1

307.7

237

CHF05

NOMESCO Finland

Transscleral laser coagulation of ciliary body

+∞

307.7

305

S01EA05

ATC

brimonidine; ophthalmic

808.2

307.7

766

H20.1

ICD-10 Finland

Chronic iridocyclitis

117.3

307.7

377

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

+∞

307.7

1715

CKD40

NOMESCO Finland

Endophotocoagulation of retina

32.1

307.7

239

H40.0

ICD-10 Finland

Glaucoma suspect

135.4

307.7

554

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

15.0

307.7

502

460

H33.0

ICD-10 Finland

Retinal detachment with retinal break

18.3

307.7

317

209

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

24.7

307.7

486

269

S01ED51

ATC

timolol, combinations; ophthalmic

285.9

307.7

1379

235

S01EC01

ATC

acetazolamide; systemic

166.7

307.7

716

S01EX03, ,

ATC

80.8

307.7

267

CKC12

NOMESCO Finland

Photocoagulation of retina

21.4

307.7

435

267

S01EE01

ATC

latanoprost; ophthalmic

95.1

307.7

860

178

XCK00

NOMESCO Finland

Perimetry

27.5

307.7

501

253

XCW99

NOMESCO Finland

Other investigative procedure of eye

10.5

307.7

647

933

S01EE03

ATC

bimatoprost; ophthalmic

92.1

307.7

298

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

371.8

307.7

378

S01EC04

ATC

brinzolamide; ophthalmic

157.9

307.7

565

S01EA03

ATC

apraclonidine; ophthalmic

119.9

307.7

346

XCH00

NOMESCO Finland

Eye pressure measurement

14.3

307.7

334

285

H34.8

ICD-10 Finland

Other retinal vascular occlusions

24.0

307.7

300

150

Z96.1

ICD-10 Finland

Presence of intraocular lens

12.0

307.7

939

1563

S01ED01

ATC

timolol; ophthalmic

94.8

307.7

664

113

114

Kela drug reimbursment

Glaucoma

186.3

307.7

1232

227

S01EE05

ATC

tafluprost; ophthalmic

76.4

307.7

387

H3603, E103,

ICD-10 Finland

65.0

298.7

165

S01BA07

ATC

fluorometholone; ophthalmic

29.2

294.2

200

CKD20

NOMESCO Finland

Removal of vitreous body substitute

63.9

283.4

157

S01EC54

ATC

brinzolamide, combinations; ophthalmic

460.0

281.3

274

S01BC03

ATC

diclofenac; ophthalmic

17.2

266.1

229

152

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

41.2

264.0

161

CKD15

NOMESCO Finland

Injection of vitreous substitute

77.6

253.6

136

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

5.3

248.9

1128

4543

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

5.5

247.4

1211

5175

CHC05

NOMESCO Finland

Iridotomy

98.7

246.4

128

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

8.8

235.6

328

446

H40.9

ICD-10 Finland

Glaucoma, unspecified

293.0

229.3

229

S01ED02

ATC

betaxolol; ophthalmic

105.5

228.9

118

H40.10

ICD-10 Finland

Capsular glaucoma with pseudoexfoliation on the anterior lens capsule

819.8

224.4

216

H3603, E113,

ICD-10 Finland

30.2

220.2

147

S01BA04

ATC

prednisolone; ophthalmic

15.0

219.3

202

151

S01BA01

ATC

dexamethasone; ophthalmic

10.5

215.4

254

278

CKC15

NOMESCO Finland

Panretinal photocoagulation

28.3

209.4

143

CHD50

NOMESCO Finland

Shunt operation on anterior chamber

+∞

208.7

196

CJB10

NOMESCO Finland

Laser discission of secondary cataract

6.1

208.6

436

906

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

15.6

200.6

180

128

S01FA04

ATC

cyclopentolate; ophthalmic

23.0

197.7

146

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

15.5

192.7

173

123

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

415.1

189.7

187

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

27.5

188.9

130

H21.0

ICD-10 Finland

Hyphaema

74.1

181.5

H26.4

ICD-10 Finland

After-cataract

5.1

177.1

461

1151

CKD10

NOMESCO Finland

Insufflation of vitreous cavity

13.9

172.2

164

129

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

274.3

171.9

173

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

+∞

170.7

161

S01EB01

ATC

pilocarpine; ophthalmic

56.4

169.6

CHB10

NOMESCO Finland

Puncture of anterior chamber of eye with irrigation

41.2

166.3

101

A10AB01

ATC

insulin (human); parenteral

9.5

161.3

203

240

H40

ICD-10 Finland

Glaucoma

59.3

160.5

CKC10

NOMESCO Finland

Local photocoagulation of retina

13.6

160.0

154

123

CS494

NOMESCO Finland

Other visual field testing

19.0

158.3

127

H16.0

ICD-10 Finland

Corneal ulcer

7.7

158.2

239

352

A10AA02, ,

ATC

8.5

153.1

211

279

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

23.0

152.3

112

WX142

NOMESCO Finland

Sub-tenon anesthesy

34.2

151.8

A10AA01, ,

ATC

11.0

149.9

167

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

32.0

144.3

CKD92

NOMESCO Finland

Combined vitrectomy and retinal procedure

17.4

143.5

120

A10AC01

ATC

insulin (human); parenteral

5.1

141.7

344

800

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

33.1

141.1

H27.0

ICD-10 Finland

Aphakia

45.8

140.4

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic

16.2

138.7

120

CHF15

NOMESCO Finland

Cryotherapy of ciliary body

+∞

136.3

129

H54.4

ICD-10 Finland

Blindness, monocular

65.3

136.0

CKD93

NOMESCO Finland

Extended combined procedure on vitreous body and retina

36.3

132.3

WX100

NOMESCO Finland

Conjunctival surface anesthesia

4.1

127.7

441

1341

H3601, E103,

ICD-10 Finland

29.4

125.5

H18.1

ICD-10 Finland

Bullous keratopathy

70.7

124.9

H36.01

ICD-10 Finland

Diabetic maculopathy

14.5

123.8

114

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

7.8

122.6

180

255

CKD70

NOMESCO Finland

Excision of preretinal or epiretinal membrane

12.1

116.7

120

106

S01FA01

ATC

atropine; ophthalmic

27.0

116.2

A10AB04

ATC

insulin lispro; parenteral

8.4

115.4

157

203

H40.8

ICD-10 Finland

Other glaucoma

1184.2

115.0

111

A10AE04

ATC

insulin glargine; parenteral

4.2

113.9

361

1025

H21.1

ICD-10 Finland

Other vascular disorders of iris and ciliary body

+∞

113.8

108

A10AB05

ATC

insulin aspart; parenteral

4.6

112.4

301

751

H34.1

ICD-10 Finland

Central retinal artery occlusion

25.5

110.9

Z94.7

ICD-10 Finland

Corneal transplant status

41.0

110.3

Z3229

NOMESCO Finland

Other healthcare associate professional

4.5

108.3

307

800

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

11.1

107.8

117

112

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

26.1

107.6

CHD65

NOMESCO Finland

Nonpenetrating glaucoma surgery

+∞

107.4

102

H25.1

ICD-10 Finland

Senile nuclear cataract

3.0

107.4

794

3809

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

7.3

107.1

165

246

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

20.4

106.6

CA1AE

NOMESCO Finland

Eye and orbita ultrasound examination

30.4

105.8

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

12.6

105.4

105

ZXA05

NOMESCO Finland

Left side

3.1

103.8

662

2915

TCG10

NOMESCO Finland

Removal of sutures from cornea

30.7

103.2

T89

ICPC

Diabetes insulin dependent

6.5

101.2

174

291

XCD10

NOMESCO Finland

Electrophysiological examination of eye

8.2

100.9

139

182

H26.02

ICD-10 Finland

Presenil cataract

8.6

97.0

128

159

ZXA00

NOMESCO Finland

Right side

2.9

96.6

691

3216

CKD94

NOMESCO Finland

Combined vitrectomy and procedure on lens through pars plana

10.9

92.9

102

A10AE05

ATC

insulin detemir; parenteral

5.1

92.9

213

465

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

7.5

91.6

136

194

H3600, E103,

ICD-10 Finland

19.4

90.4

H26.3

ICD-10 Finland

Drug-induced cataract

21.7

89.6

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

21.7

89.6

XCW10

NOMESCO Finland

Assessment of vision

13.5

88.4

S01BC05

ATC

ketorolac; ophthalmic

5.2

87.7

192

402

T85.2

ICD-10 Finland

Mechanical complication of intraocular lens

27.0

87.2

H04AA01

ATC

glucagon; nasal, parenteral

10.1

87.0

101

106

CHD99

NOMESCO Finland

Other filtering operation

+∞

85.1

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

4.3

83.6

239

621

A10AD01

ATC

insulin (human); parenteral

8.4

83.3

112

142

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

15.6

82.3

ZXA10

NOMESCO Finland

Bilateral

3.0

81.6

483

2000

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

14.2

81.3

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

6.5

80.9

138

228

CHD00

NOMESCO Finland

Laser trabeculoplasty

212.3

79.0

XCH05

NOMESCO Finland

Eye pressure longterm registration

124.5

77.6

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

7.6

77.3

113

158

L04AX03

ATC

methotrexate; systemic

3.7

75.6

268

810

H40.20

ICD-10 Finland

Acute glaucoma with closed ventricular angle

+∞

75.6

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

3.4

74.9

312

1047

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

11.0

74.7

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

11.5

74.1

H04.10

ICD-10 Finland

Dry eye syndrome

3.4

73.7

303

1008

XCD20

NOMESCO Finland

Photoangiography of eye

8.6

73.7

117

H3601, E113,

ICD-10 Finland

8.6

73.2

118

H40.3

ICD-10 Finland

Glaucoma secondary to eye trauma

727.4

71.6

L04AB04

ATC

adalimumab; parenteral

8.5

71.4

116

H16.9

ICD-10 Finland

Keratitis, unspecified

9.4

70.7

CHD15

NOMESCO Finland

Trabeculectomy and iridectomy

716.6

70.6

CKC60

NOMESCO Finland

Local buckling of sclera using implant

18.6

70.1

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

14.7

67.5

E10

ICD-10 Finland

Type 1 diabetes mellitus

9.5

65.5

S01FA02

ATC

scopolamine; ophthalmic

13.0

65.1

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

6.4

65.0

111

183

CKC30

NOMESCO Finland

Cryopexy of detached retina

17.6

64.6

TCA20

NOMESCO Finland

Peribulbar therapeutic injection into orbit

328.8

63.9

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

19.0

63.2

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

21.9

63.2

H36.00

ICD-10 Finland

Diabetic background retinopathy

10.0

63.1

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

17.3

62.8

L04AA01

ATC

[U] ciclosporin

11.4

62.6

WX002

NOMESCO Finland

Sedation and analgesia

2.6

61.6

457

2090

CKC70

NOMESCO Finland

Circular buckling of sclera

21.5

61.3

H27.1

ICD-10 Finland

Dislocation of lens

22.0

60.5

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

78.7

60.5

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

25.3

59.6

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.6

59.2

148

344

S01EE51

ATC

latanoprost and netarsudil; ophthalmic

207.0

58.4

H19.1*B00.5

ICD-10 Finland

Herpesviral keratoconjunctivitis

12.8

58.3

H57.1

ICD-10 Finland

Ocular pain

5.2

58.2

124

252

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

11.3

57.5

L04AA06

ATC

mycophenolic acid; systemic

7.8

56.7

107

103

Kela drug reimbursment

Diabetes, insulin-treated

2.3

55.3

639

3537

A10AE06

ATC

insulin degludec; parenteral

5.1

54.9

120

249

127

Kela drug reimbursment

Transplant complication

8.7

54.8

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.8

54.5

102

184

CKD60

NOMESCO Finland

Anterior vitrectomy

10.9

54.4

R5210

NOMESCO Finland

Assessment of the improvements needed in the living environment

20.4

52.2

ZXE10

NOMESCO Finland

More than one and less than three hours

2.2

52.1

734

4376

S01AD03

ATC

aciclovir; ophthalmic

5.0

52.0

117

249

H3600, E113,

ICD-10 Finland

8.9

51.1

H40.11

ICD-10 Finland

Low pressure glaucoma

73.5

50.3

L01BA01

ATC

methotrexate; systemic

4.7

50.1

120

269

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

9.4

49.7

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

12.6

49.7

TK800

NOMESCO Finland

Hemodialysis

5.9

49.7

164

Z94.0

ICD-10 Finland

Kidney transplant status

10.0

49.4

V03AE01

ATC

polystyrene sulfonate; oral

7.2

49.4

106

H20.8

ICD-10 Finland

Other iridocyclitis

19.0

49.2

A11CC03

ATC

alfacalcidol; systemic

5.5

48.0

184

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

6.0

47.8

149

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.2

47.7

534

2886

NHQ40

NOMESCO Finland

Amputation of toe

6.4

47.4

130

V03AE02

ATC

sevelamer; oral

15.5

46.9

H33.4

ICD-10 Finland

Traction detachment of retina

76.7

46.2

H44.5

ICD-10 Finland

Degenerated conditions of globe

236.1

45.2

Z49.1

ICD-10 Finland

Extracorporeal dialysis

7.1

45.1

101

CS2P4

NOMESCO Finland

Optic nerve head imaging

65.6

44.4

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

15.3

44.3

H18.8

ICD-10 Finland

Other specified disorders of cornea

14.6

44.3

CKD50

NOMESCO Finland

Endodiathermy of retina

120.7

44.0

H40.22

ICD-10 Finland

Chronic glaucoma with closed ventricular angle

+∞

43.9

Z3231

NOMESCO Finland

Registered nurse

2.1

43.8

568

3232

A10AA03, ,

ATC

8.8

43.6

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

14.1

43.4

ZX198

NOMESCO Finland

Other local administration

8.7

43.1

CGG45

NOMESCO Finland

Full thickness transplantation of cornea using homograft

92.4

41.0

CHD35

NOMESCO Finland

Laser goniopuncture

+∞

40.8

S01EA02

ATC

dipivefrine; ophthalmic

406.7

40.3

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

12.4

40.3

A12AA04

ATC

calcium carbonate; oral

6.1

40.0

118

CG2T4

NOMESCO Finland

Topography assessment of cornea

10.2

39.9

SPAT1262

SPAT

Handing over of treatment supplies

2.3

39.7

387

1957

ZXC20

NOMESCO Finland

Use of chemical agents

5.5

39.5

144

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

8.1

39.3

ZXE00

NOMESCO Finland

One hour or less

2.0

39.3

729

4680

SPAT1009

SPAT

Measurement of intraocular pressure

7.9

39.3

CD2S4

NOMESCO Finland

Photography of eye

13.0

38.4

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

4.8

38.4

190

S01AX11

ATC

[U] ofloxacin

3.9

38.3

118

320

H40.6

ICD-10 Finland

Glaucoma secondary to drugs

+∞

37.6

ZXD20

NOMESCO Finland

Day surgery

2.5

37.3

270

1195

137

Kela drug reimbursment

Uraemia requiring dialysis

8.9

36.8

L04AD02

ATC

tacrolimus; systemic

8.6

36.6

CG2X4

NOMESCO Finland

Optical coherence tomography (OCT) of cornea

12.2

36.0

H54.1

ICD-10 Finland

Severe visual impairment, binocular

81.9

35.9

3641A

ICD-9 Finland

Disorders of iris and ciliary body, Chronic iridocyclitis

188.9

35.9

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

11.1

35.6

3656X

ICD-9 Finland

Glaucoma associated with other ocular disorders[GLAUCOMA SECUNDARIA ALIA SEU NUD]

+∞

35.5

B05DA

ATC

Isotonic solutions

9.7

35.1

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.1

34.9

152

515

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.7

34.9

201

795

H30.2

ICD-10 Finland

Posterior cyclitis

39.1

33.5

H25.2

ICD-10 Finland

Senile cataract, morgagnian type

11.9

33.5

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.3

33.3

283

1342

3626

FHL

Extracapsular cataract surgery and implantation of an artificial lens

5.3

33.0

130

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

11.1

32.9

TCF00

NOMESCO Finland

Subconjunctival therapeutic injection

38.1

32.5

TCA15

NOMESCO Finland

Retrobulbar therapeutic injection into orbit

+∞

32.4

196

Kela drug reimbursment

Paricalcitol and cinacalcet

11.2

32.1

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

35.0

31.9

H35.36

ICD-10 Finland

Macular cyst

10.2

31.9

N18.8

ICD-10 Finland

Other chronic renal failure

4.2

31.8

216

H33.5

ICD-10 Finland

Other retinal detachments

9.0

31.6

TCG00

NOMESCO Finland

Protection of cornea and sclera with soft lens

32.3

31.4

ZXD05

NOMESCO Finland

Urgent procedure

1.9

31.2

591

3751

M45

ICD-10 Finland

Ankylosing spondylitis

5.0

31.1

137

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

31.0

905

6548

ZXD10

NOMESCO Finland

Scheduled procedure

1.8

30.8

688

4592

CFD10

NOMESCO Finland

Repair of conjunctiva

162.9

30.8

H54.5

ICD-10 Finland

Severe visual impairment, monocular

10.5

30.7

F28

ICPC

Limited function/disability (F)

10.8

30.5

Z49.0

ICD-10 Finland

Preparatory care for dialysis

7.2

30.2

CFW99

NOMESCO Finland

Other operation on conjunctiva

307.6

29.9

B05DB

ATC

Hypertonic solutions

9.6

29.8

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

9.6

29.8

Z49.2

ICD-10 Finland

Other dialysis

8.6

29.7

H54.0

ICD-10 Finland

Blindness, binocular

51.0

29.4

B03XA02

ATC

darbepoetin alfa; parenteral

4.3

29.4

185

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.2

29.3

300

1531

37520

ICD-8 Finland

Glaucoma, Secondary

+∞

29.2

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

40.9

29.0

S97

ICPC

Chronic ulcer skin

2.7

28.9

172

689

177

Kela drug reimbursment

Insulin glargine 300 U / ml

5.0

28.7

131

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

5.2

28.6

116

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.3

28.3

248

1186

CA1ME

NOMESCO Finland

Ultrasound oculometry

8.1

28.2

CK2M4

NOMESCO Finland

Macular light layer imaging (OCT)

8.9

28.1

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

2.8

28.0

151

575

L04AD01

ATC

ciclosporin; systemic

5.8

27.8

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

2.9

27.6

133

477

3651A

ICD-9 Finland

Glaucoma, Open-angle glaucoma[GLAUCOMA SIMPLEX (AVOKULMA)]

+∞

27.2

H28.0*E10.3

ICD-10 Finland

Other specified diabetes mellitus - Diabetic cataract

63.1

27.0

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

2.8

26.9

141

529

H33.3

ICD-10 Finland

Retinal breaks without detachment

3.7

26.7

245

C09AA02

ATC

enalapril; systemic

1.9

26.6

422

2509

F38

ICPC

Eye, Other laboratory test NEC

5.8

26.4

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

10.5

26.3

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

5.9

26.3

3711

FHL

Cyclodiateria or cryocoagulation

+∞

26.1

H3603, E107,

ICD-10 Finland

137.1

25.7

3643

FHL

Vitrectomy through pars Plana

33.6

25.6

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

25.5

161

664

F99

ICPC

Eye/adnexa disease other

8.8

25.4

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

28.9

25.4

H25.8

ICD-10 Finland

Other senile cataract

2.1

25.4

261

1329

H40.19

ICD-10 Finland

Other primary glaucoma with open ventricular angle

+∞

25.1

3663A

ICD-9 Finland

Cataract secondary to ocular disorders

30.5

25.0

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

30.5

25.0

S05.1

ICD-10 Finland

Contusion of eyeball and orbital tissues

5.7

24.8

L04AX01

ATC

azathioprine; systemic

3.4

24.7

283

ZX120

NOMESCO Finland

Intravenous

2.3

24.7

199

917

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

6.9

24.7

A10AD05

ATC

insulin aspart; parenteral

4.2

24.6

166

C08CA01

ATC

amlodipine; oral

1.7

24.4

734

5239

C03CA01

ATC

furosemide; systemic

1.7

24.2

689

4841

H34.2

ICD-10 Finland

Other retinal artery occlusions

9.0

24.2

H54.7

ICD-10 Finland

Unspecified visual loss

9.0

24.2

F93

ICPC

Glaucoma

29.6

24.1

H04.5

ICD-10 Finland

Stenosis and insufficiency of lacrimal passages

4.3

24.1

147

L88

ICPC

Rheumatoid/seropositive arthritis

3.4

24.0

278

CDC00

NOMESCO Finland

Enucleation of eye

126.8

23.6

N18.0

ICD-10 Finland

End-stage renal disease

5.7

23.6

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.5

23.6

163

701

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

3.3

23.4

277

S05.0

ICD-10 Finland

Injury of conjunctiva and corneal abrasion without mention of foreign body

4.6

23.2

126

CKD95

NOMESCO Finland

Extended combined vitectomy and lens procedure through pars plana

18.8

23.1

3708

FHL

Trabeculectomy or equivalent

+∞

23.0

S01EX

ATC

Other antiglaucoma preparations

+∞

23.0

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

5.8

22.9

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

5.9

22.8

SPAT1229

SPAT

Assessment of need for aid

2.3

22.7

178

809

H36.02

ICD-10 Finland

Preproliferative diabetic retinopathy

26.3

22.7

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

3.1

22.6

325

A07EC01

ATC

sulfasalazine; oral, rectal

2.4

22.5

158

684

Z90.0

ICD-10 Finland

Acquired absence of part of head and neck

45.6

22.4

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.7

22.3

125

485

H35.0

ICD-10 Finland

Background retinopathy and retinal vascular changes

8.0

22.2

3719

FHL

Other measure in this category

+∞

21.9

H22.1*M45

ICD-10 Finland

Iridocyclitis in ankylosing spondylitis

39.2

21.7

H25.0

ICD-10 Finland

Senile incipient cataract

2.5

21.7

143

601

S01AA01

ATC

chloramphenicol; ophthalmic

2.9

21.5

107

390

C69.30

ICD-10 Finland

Malignant tumor of the chorioidea without histology

23.5

21.3

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

21.1

446

2866

H15.1

ICD-10 Finland

Episcleritis

5.6

21.1

36402

ICD-8 Finland

Iritis, Iridocyclitis, uveitis chronica

60.8

20.9

CJF30

NOMESCO Finland

Reduction of dislocation of artificial lens

19.7

20.8

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

20.8

612

4297

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

20.8

1108

9003

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

20.6

349

2099

H40.12

ICD-10 Finland

Pigmentary glaucoma

212.5

20.6

J01FF01

ATC

clindamycin; systemic

1.7

20.6

466

3050

CJ2M4

NOMESCO Finland

Scans and measurement printouts for intraocular lens power calculation

6.6

20.5

3610A

ICD-9 Finland

Retinal detachments and defects, Retinal detachment with retinal defect

17.1

20.5

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.0

20.4

334

3793A

ICD-9 Finland

Other disorders of eye, Aphakia and other disorders of lens[APHAKIA]

33.0

20.2

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.5

20.2

134

565

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

6.5

20.1

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

6.6

20.1

H18.2

ICD-10 Finland

Other corneal oedema

27.4

20.0

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

4.3

20.0

120

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

20.0

411

2615

CK2P4

NOMESCO Finland

Optic nerve head light layer imaging (OCT)

58.2

19.9

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

19.9

265

1474

3656F

ICD-9 Finland

Glaucoma associated with other ocular disorders[GLAUCOMA POST UVEITIDEM]

+∞

19.8

H3603, E109,

ICD-10 Finland

74.4

19.7

C10AA01

ATC

simvastatin; oral

1.6

19.3

777

5859

ZYC01

NOMESCO Finland

Remote contact by phone

2.6

19.2

116

467

C69.32

ICD-10 Finland

Malignant tumor of the chorioidea melanoma

46.6

19.2

M14.6*E10.6

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic neuropathic

46.6

19.2

CKE60

NOMESCO Finland

Brachytherapy of choroid and retina

26.4

19.1

CKE65

NOMESCO Finland

Removal of brachytherapeutic plate from eye

26.4

19.1

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.6

19.0

175

CJF00

NOMESCO Finland

Secondary implantation of artificial lens in anterior chamber

34.7

18.9

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

18.7

474

3184

F43

ICPC

Eye, Other diagnostic procedure

4.6

18.5

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

6.3

18.5

H05BX01

ATC

cinacalcet; oral

6.9

18.3

Z5132

NOMESCO Finland

Nursing associate professional

7.5

18.3

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

7.5

18.3

H17.8

ICD-10 Finland

Other corneal scars and opacities

22.0

18.2

T90

ICPC

Diabetes non-insulin dependent

1.7

18.1

443

2944

H35.6

ICD-10 Finland

Retinal haemorrhage

6.5

17.9

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

3.1

17.9

243

CFB00

NOMESCO Finland

Suture of conjunctiva

67.3

17.7

37403

ICD-8 Finland

Cataract, Complicata

96.1

17.6

S01KA02

ATC

hypromellose; ophthalmic

4.6

17.6

CGG99

NOMESCO Finland

Other reconstructive operations on cornea and sclera

181.8

17.5

NGQ20

NOMESCO Finland

Amputation of lower leg

5.9

17.5

B03XA01

ATC

erythropoietin; parenteral

5.2

17.4

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

7.1

17.4

2501B

ICD-9 Finland

Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]

24.3

17.3

R4180

NOMESCO Finland

Podiatric therapy

4.6

17.3

205

Kela drug reimbursment

Chronic hypertension

1.6

17.3

546

3862

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

4.3

17.2

108

L04AB06

ATC

golimumab; parenteral

7.6

17.0

CJF45

NOMESCO Finland

Removal and implantation of artificial lens in anterior chamber with iridectomy or iridotomy

25.9

16.9

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

6.3

16.8

3649

FHL

Other measure in this category

+∞

16.7

OAB50, ,

SPAT

2.2

16.7

155

755

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

12.8

16.6

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

6.8

16.6

H02AB06

ATC

prednisolone; systemic

1.5

16.6

801

6224

F29

ICPC

Eye symptom/complaint other

2.0

16.5

183

952

H01.0

ICD-10 Finland

Blepharitis

2.4

16.5

115

496

C02AC05

ATC

moxonidine; oral

2.5

16.4

109

460

CG2S4

NOMESCO Finland

Photography of cornea

12.9

16.2

H26.1

ICD-10 Finland

Traumatic cataract

11.8

16.0

Z97.0

ICD-10 Finland

Presence of artificial eye

48.0

16.0

CKD99

NOMESCO Finland

Other intraoclular operations on vitreous body and retina

48.0

16.0

I79.2*E10.5

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

48.0

16.0

H44.0

ICD-10 Finland

Purulent endophthalmitis

24.7

16.0

A10BB01

ATC

glibenclamide; oral

2.4

16.0

112

484

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.4

15.9

171

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.5

15.9

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

15.6

227

1295

B01AC04

ATC

clopidogrel; oral

1.7

15.6

333

2126

H22.1*D86.8

ICD-10 Finland

Iridocyclitis in sarcoidosis

85.9

15.6

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.8

15.5

286

H43.8

ICD-10 Finland

Other disorders of vitreous body

2.1

15.5

163

832

CK9F4

NOMESCO Finland

Fluorescein angiography (FAG) of choroid and retina

6.7

15.3

Z2221

NOMESCO Finland

Medical doctor

1.6

15.3

451

3124

S01BA09

ATC

clobetasone; ophthalmic

28.9

15.2

H33.2

ICD-10 Finland

Serous retinal detachment

14.1

15.0

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

15.0

655

4948

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

14.9

247

1467

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.0

14.8

232

H40.1

ICD-10 Finland

Primary open-angle glaucoma

57.2

14.8

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

14.6

417

2861

3650A

ICD-9 Finland

Glaucoma, Borderline glaucoma [glaucoma suspect][SUSPICIO GLAUCOMATIS (AVOKULMA)]

+∞

14.6

H221, M084,

ICD-10 Finland

+∞

14.6

CHC03

NOMESCO Finland

Laser iridoplasty

+∞

14.6

Q15.0

ICD-10 Finland

Congenital glaucoma

+∞

14.6

CHD10

NOMESCO Finland

Trabeculectomy

+∞

14.6

TCH12

NOMESCO Finland

Sample aspiration from anterior chambre

+∞

14.6

36400

ICD-8 Finland

Iritis, Iridocyclitis acuta

12.0

14.6

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

6.6

14.5

CKD45

NOMESCO Finland

Endocryotherapy of retina

151.2

14.5

CHW99

NOMESCO Finland

Other operation on anterior chamber, anterior chamber angle, iris or ciliary body

151.2

14.5

BEF00, ,

SPAT

5.9

14.5

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

14.4

272

1675

WZC30

NOMESCO Finland

Teaching

1.7

14.4

276

1707

L04AA13

ATC

[U] leflunomide

3.4

14.3

148

S01FA06

ATC

tropicamide; ophthalmic

27.4

14.3

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

4.2

14.2

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

14.2

220

1278

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.3

14.2

110

497

C08CA13

ATC

lercanidipine; oral

1.7

14.0

262

1608

H11.3

ICD-10 Finland

Conjunctival haemorrhage

2.5

13.9

351

3640A

ICD-9 Finland

Disorders of iris and ciliary body, Acute and subacute iridocyclitis

30.3

13.9

S18

ICPC

Laceration/cut

1.5

13.8

763

6018

E10.01

ICD-10 Finland

Insulin-dependent diabetes diabetic coma with hyperglycemia

53.8

13.8

37872

ICD-8 Finland

Other diseases of eye, Aphakia artefacta, acquisita

24.0

13.8

CJF15

NOMESCO Finland

Secondary implantation of skleral fixed artificial lens in posterior chamber

24.0

13.8

H3602, E103,

ICD-10 Finland

20.2

13.8

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

13.7

131

645

H43.3

ICD-10 Finland

Other vitreous opacities

4.4

13.6

T86.8

ICD-10 Finland

Failure and rejection of other transplanted organs and tissues

75.7

13.6

L04AA17

ATC

[U] adalimumab

14.8

13.6

H35.29

ICD-10 Finland

Other proliferative retinopathy

+∞

13.6

CGG60

NOMESCO Finland

Reinforcement of sclera using graft

+∞

13.6

3651B

ICD-9 Finland

Glaucoma, Open-angle glaucoma[GLAUCOMA CAPSULARE (AVOKULMA)]

+∞

13.6

CDC10

NOMESCO Finland

Enucleation of eye with insertion of prosthesis

+∞

13.6

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

13.5

487

3513

J01DB01

ATC

cefalexin; oral

1.6

13.5

1331

11771

H18.6

ICD-10 Finland

Keratoconus

11.0

13.5

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

34.3

13.5

T85.3

ICD-10 Finland

Mechanical complication of other ocular prosthetic devices, implants and grafts

141.1

13.5

CHB99

NOMESCO Finland

Other operation on anterior chamber and anterior chamber angle

141.1

13.5

Q12.0

ICD-10 Finland

Congenital cataract

26.0

13.4

CKA10

NOMESCO Finland

Biopsy of vitreous body

21.3

13.3

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

13.3

1086

9217

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.7

13.3

275

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

3.4

13.2

136

3620B

ICD-9 Finland

Other retinal disorders, Diabetic retinopathy[RETINOPATHIA DIABETICA PROLIFERATIVA]

40.4

13.2

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.8

13.2

231

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

13.1

427

3011

F01

ICPC

Eye pain

3.0

13.1

188

SPAT1263

SPAT

Sampling

1.5

13.1

652

5025

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

13.1

454

3246

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

6.0

13.1

E0000UV, ,

ATC

1.5

13.0

643

4945

CHB15

NOMESCO Finland

Puncture of anterior chamber of eye with replacement of aqueous

28.6

13.0

H16.2

ICD-10 Finland

Keratoconjunctivitis

6.2

12.9

2504B

ICD-9 Finland

Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]

19.2

12.9

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

4.9

12.9

3718X

ICD-9 Finland

Corneal opacity and other disorders of cornea, Other corneal disorders

50.4

12.8

A10AB06

ATC

insulin glulisine; parenteral

4.6

12.8

AA1AD

NOMESCO Finland

CT of head and brain

1.5

12.8

525

3885

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

14.2

12.8

H18.4

ICD-10 Finland

Corneal degeneration

9.7

12.7

PE1AT

NOMESCO Finland

Femoral artery PTA

3.9

12.6

74439

ICD-8 Finland

Congenital anomalies of eye, Cataracta NUD

70.4

12.6

3747

FHL

Combined ablation and vitreous surgery with coagulation

70.4

12.6

CHC00

NOMESCO Finland

Iridotomy

+∞

12.5

37597

ICD-8 Finland

Glaucoma, Suspicio glaucomatis

+∞

12.5

37510

ICD-8 Finland

Glaucoma, Chronicum simplex

+∞

12.5

H3603, H405,

ICD-10 Finland

+∞

12.5

S05.6

ICD-10 Finland

Penetrating wound of eyeball without foreign body

20.2

12.5

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

12.4

458

3313

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

12.3

199

1171

N02BE01

ATC

paracetamol; systemic, rectal

1.6

12.2

1460

13282

CKW99

NOMESCO Finland

Other operation on choroid, vitreous body and retina

9.0

12.2

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

12.2

152

822

H30.9

ICD-10 Finland

Chorioretinal inflammation, unspecified

37.8

12.2

C10AX09

ATC

ezetimibe; oral

1.7

12.1

277

1791

CJF20

NOMESCO Finland

Removal of artificial lens

26.9

12.0

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.1

12.0

112

546

H19.1

ICD-10 Finland

Herpesviral keratitis and keratoconjunctivitis

13.5

11.9

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.1

11.8

167

TK810

NOMESCO Finland

Hemofiltration

5.9

11.8

A46

ICD-10 Finland

Erysipelas

1.6

11.8

273

1771

L28

ICPC

Limited function/disability (L)

1.6

11.8

357

2470

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.4

11.7

330

A02BC02

ATC

pantoprazole; systemic

1.4

11.7

1099

9463

3792A

ICD-9 Finland

Other disorders of eye, Disorders of vitreous body

30.2

11.6

CWW99

NOMESCO Finland

Other reoperation on eye and adjacent structures

65.4

11.6

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

19.1

11.6

H3602, E113,

ICD-10 Finland

19.1

11.6

H3603, E106,

ICD-10 Finland

23.1

11.6

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

11.5

217

1332

H221, M083,

ICD-10 Finland

+∞

11.5

JLE03

NOMESCO Finland

Allogenic total transplantation of pancreas with pancreaticoenterostomy

120.8

11.4

H44.4

ICD-10 Finland

Hypotony of eye

120.8

11.4

H18.5

ICD-10 Finland

Hereditary corneal dystrophies

4.7

11.4

C10AA05

ATC

atorvastatin; oral

1.4

11.4

699

5564

S01GX01

ATC

cromoglicic acid; ophthalmic

1.6

11.3

268

1747

R4180, ,

SPAT

4.0

11.3

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.7

11.3

239

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

11.3

290

1929

R3120

NOMESCO Finland

Training in mobility skills

9.7

11.2

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

11.2

557

4259

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.2

11.2

414

W44

ICD-10 Finland

Foreign body entering into or through eye or natural orifice

3.7

11.1

H44.2

ICD-10 Finland

Degenerative myopia

20.2

11.1

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.4

11.1

116

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

11.1

323

2211

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

4.0

11.0

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.8

11.0

202

WX213

NOMESCO Finland

Lower leg blockade

4.5

11.0

H02.4

ICD-10 Finland

Ptosis of eyelid

2.7

10.9

220

25008

ICD-8 Finland

Diabetes mellitus, Complicatio alia definita

15.6

10.8

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.9

10.8

176

H17.9

ICD-10 Finland

Corneal scar and opacity, unspecified

17.9

10.7

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

4.8

10.7

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

10.7

581

4510

25002

ICD-8 Finland

Diabetes mellitus, Retinopathia diabetica

21.6

10.7

3744

FHL

Pericardial identification surgery with coagulation (includes epi- and intrascleral indications and eg Lincoff catheter)

21.6

10.7

H17.1

ICD-10 Finland

Other central corneal opacity

13.0

10.6

F94

ICPC

Blindness

60.4

10.6

CH2S4

NOMESCO Finland

Photography of iris

60.4

10.6

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

2.0

10.6

111

566

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

5.1

10.5

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

10.5

234

1500

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

10.5

550

4238

2507B

ICD-9 Finland

Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]

14.3

10.5

CGG31

NOMESCO Finland

Posterior corneal lamellar transplantation

14.3

10.5

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.0

10.4

107

541

L04AB01

ATC

etanercept; parenteral

4.1

10.4

S01FB01

ATC

phenylephrine; ophthalmic

110.7

10.4

H16.3

ICD-10 Finland

Interstitial and deep keratitis

110.7

10.4

CDC40

NOMESCO Finland

Evisceration of eye with insertion of prosthesis

110.7

10.4

N0830, E102,

ICD-10 Finland

110.7

10.4

ZZL00

NOMESCO Finland

Free graft of amniotic membrane

+∞

10.4

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.5

10.4

255

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

10.4

598

4684

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.3

10.4

361

Z2446

NOMESCO Finland

Social worker

2.0

10.4

118

619

L84

ICD-10 Finland

Corns and callosities

2.4

10.4

286

H34.9

ICD-10 Finland

Retinal vascular occlusion, unspecified

16.1

10.3

CL2L4

NOMESCO Finland

Wide-field fundus photography for diabetic retinopathy screening

32.7

10.3

N083, E102,

ICD-10 Finland

32.7

10.3

3604

FHL

Penetration of the cornea

32.7

10.3

L17

ICPC

Foot/toe symptom/complaint

1.5

10.3

463

3465

SPAT1301

SPAT

No procedures

1.4

10.3

496

3761

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.8

10.3

181

CJF10

NOMESCO Finland

Secondary implantation of artificial lens in posterior chamber

18.9

10.3

V03AE03

ATC

lanthanum carbonate; oral

9.6

10.3

E16.0

ICD-10 Finland

Drug-induced hypoglycaemia without coma

9.6

10.3

QDB10, ,

SPAT

2.7

10.2

210

RS221, ,

NOMESCO Finland

3.7

10.2

P01BA02

ATC

hydroxychloroquine; oral

1.9

10.1

123

660

XCC00

NOMESCO Finland

Investigative irrigation of lacrimal passages

3.9

10.1

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

10.1

144

815

L04AA11

ATC

[U] etanercept

11.4

10.1

CGF10

NOMESCO Finland

Suture of laceration of cornea

14.7

10.0

XCD00

NOMESCO Finland

Clinical examination of eye in general anaesthesia

40.3

10.0

A28

ICPC

Limited function/disability NOS

1.5

10.0

351

2500

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

9.9

473

3578

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

9.9

171

1025

CJE15

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in anterior chamber and iridectomy or iridotomy

4.3

9.9

H53.4

ICD-10 Finland

Visual field defects

2.9

9.8

152

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

5.2

9.8

CKC65

NOMESCO Finland

Removal of buckling implant from sclera

26.2

9.8

8720/3-C69.3

ICD-O-3

Malignant melanoma, NOS, of choroid

20.1

9.8

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

9.6

9.8

SPAT1260

SPAT

Consultation of another employee

1.6

9.7

271

1834

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.6

9.7

210

4AA12, ,

NOMESCO Finland

13.4

9.7

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.5

9.7

240

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.4

9.6

1186

H16.1

ICD-10 Finland

Other superficial keratitis without conjunctivitis

10.1

9.5

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.1

9.4

450

N08.32

ICD-10 Finland

Glomerular disorders in diabetes mellitus kidney failure

100.6

9.4

CGF35

NOMESCO Finland

Repair of cornea using graft

100.6

9.4

M65.3

ICD-10 Finland

Trigger finger

2.2

9.4

357

M14.6

ICD-10 Finland

Neuropathic arthropathy

30.2

9.4

H40.29

ICD-10 Finland

Other [primary] glaucoma with closed ventricular angle

+∞

9.4

H3603, E117,

ICD-10 Finland

+∞

9.4

3656C

ICD-9 Finland

Glaucoma associated with other ocular disorders[GLAUCOMA NEOVASCULARE]

+∞

9.4

C69.42

ICD-10 Finland

Malignant tumor of ciliary melanoma

+∞

9.4

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.2

9.4

338

J01MA02

ATC

ciprofloxacin; systemic

1.4

9.3

641

5153

S20

ICPC

Corn/callosity

2.8

9.3

163

R11

ICD-10 Finland

Nausea and vomiting

1.8

9.3

149

874

WX144

NOMESCO Finland

Subconjunctival anesthesy

3.8

9.2

TK820

NOMESCO Finland

Peritoneal dialysis

7.3

9.2

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

3.2

9.2

115

I50.0

ICD-10 Finland

Congestive heart failure

1.7

9.2

175

1076

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

3.9

9.1

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

9.1

121

670

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

3.0

9.1

132

H55

ICD-10 Finland

Nystagmus and other irregular eye movements

11.5

9.1

N03AX16

ATC

[U] pregabalin

1.5

9.0

349

2528

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

9.0

300

2107

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.4

9.0

242

36409

ICD-8 Finland

Iritis, Unspecified

36.9

9.0

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

9.0

119

657

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

7.5

8.9

PAW37

NOMESCO Finland

Biopsy of temporal artery

4.9

8.8

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.7

8.8

155

932

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

8.8

357

2608

C09CA01

ATC

losartan; oral

1.4

8.7

412

3097

CGF45

NOMESCO Finland

Suture of laceration of sclera

50.2

8.7

H30.0

ICD-10 Finland

Focal chorioretinal inflammation

50.2

8.7

E87.5

ICD-10 Finland

Hyperkalaemia

2.7

8.7

169

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

8.7

150

899

N03AX12

ATC

[U] gabapentin; oral

1.6

8.6

242

1638

L04AB05

ATC

certolizumab pegol; parenteral

11.6

8.6

B00.5

ICD-10 Finland

Herpesviral ocular disease

11.6

8.6

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.0

8.6

474

H16.8

ICD-10 Finland

Other keratitis

16.4

8.6

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.8

8.5

118

661

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

10.1

8.5

CF2S4

NOMESCO Finland

Photography of conjunctiva

20.1

8.5

CM2X4

NOMESCO Finland

Follow-up OCT of age-related macular degeneration lesions

4.2

8.5

H3603, H431,

ICD-10 Finland

90.5

8.4

CBH30

NOMESCO Finland

Tarsorraphy

90.5

8.4

37100

ICD-8 Finland

Corneal opacity, Cicatrix (nubecula, macula, leucoma) cornea

90.5

8.4

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

3.0

8.4

127

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.7

8.4

149

900

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

7.9

8.4

A10BH05

ATC

linagliptin; oral

1.9

8.4

101

542

3656A

ICD-9 Finland

Glaucoma associated with other ocular disorders[PUPILLARIBLOKIN TAI SEKLUUSION AIHEUTTAMA GLAUKOOMA]

+∞

8.3

H36.04

ICD-10 Finland

Severe diabetic ophthalmopathy

+∞

8.3

M86.6

ICD-10 Finland

Other chronic osteomyelitis

8.6

8.3

G63.2

ICD-10 Finland

Diabetic polyneuropathy

8.6

8.3

A10AD04

ATC

insulin lispro; parenteral

8.6

8.3

CCD60

NOMESCO Finland

Transnasal dacryocystorhinostomy

9.5

8.3

C09BA02

ATC

enalapril and diuretics; systemic

1.7

8.2

143

858

A10BA02

ATC

metformin; oral

1.4

8.2

480

3742

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

8.2

209

1384

N19

ICD-10 Finland

Unspecified kidney failure

2.0

8.1

413

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

8.1

486

3801

TCC30

NOMESCO Finland

Intubation of lacrimal canaliculus/duct

4.6

8.1

J05AB01

ATC

aciclovir; systemic

1.5

8.1

315

2280

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.0

8.1

119

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

8.1

125

725

SPAT1310

SPAT

Counselling related to known health issue

1.4

8.1

454

3513

J01CF05

ATC

flucloxacillin; systemic

1.8

8.1

114

643

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

8.1

188

1217

H3603, E116,

ICD-10 Finland

33.5

8.1

H22.1

ICD-10 Finland

Iridocyclitis in other diseases classified elsewhere

33.5

8.1

H30.1

ICD-10 Finland

Disseminated chorioretinal inflammation

33.5

8.1

H44.1

ICD-10 Finland

Other endophthalmitis

17.3

8.1

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.2

8.1

300

C09AA05

ATC

ramipril; oral

1.4

8.0

435

3346

RJ521, ,

NOMESCO Finland

22.1

8.0

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

6.3

8.0

WX199

NOMESCO Finland

Other local analgesia

2.3

8.0

275

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.7

8.0

160

998

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

2.8

7.9

137

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.0

7.9

110

S01XA18

ATC

ciclosporin; ophthalmic

6.6

7.9

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

7.8

7.9

SPAT1216

SPAT

Assessment of functional ability

1.5

7.9

276

1957

CJD20

NOMESCO Finland

Extracapsular cataract extraction with implantation of artificial lens in posterior chamber

10.8

7.8

RD210, ,

NOMESCO Finland

3.1

7.8

106

R42

ICD-10 Finland

Dizziness and giddiness

1.4

7.7

373

2809

H21.9

ICD-10 Finland

Disorder of iris and ciliary body, unspecified

45.2

7.7

H3603, E108,

ICD-10 Finland

45.2

7.7

3625

FHL

Extracapsular nuclear cataract removal

45.2

7.7

C69.40

ICD-10 Finland

Malignant tumor of ciliary body without histology

45.2

7.7

CA1AD

NOMESCO Finland

Orbita CT

15.1

7.7

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

2.5

7.6

199

1LA05, ,

NOMESCO Finland

6.7

7.6

H3601, E116,

ICD-10 Finland

25.1

7.6

H28.0

ICD-10 Finland

Diabetic cataract

25.1

7.6

H22.0*B00.5

ICD-10 Finland

Herpesviral iridocyclitis

25.1

7.6

UJF32

NOMESCO Finland

Coloscopy

1.4

7.6

406

3113

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

1.9

7.5

467

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.9

7.5

460

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

8.9

7.5

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

7.5

122

718

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

7.5

203

1362

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

7.5

265

1882

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

7.5

426

3300

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

4.4

7.4

CJF50

NOMESCO Finland

Removal and implantation of artificial lens in posterior chamber

80.4

7.4

CKD75

NOMESCO Finland

Retinotomy

80.4

7.4

NHG20

NOMESCO Finland

Fusion of talocrural joint

6.5

7.4

A41.9

ICD-10 Finland

Sepsis, unspecified

2.1

7.4

331

ZZA00

NOMESCO Finland

Split skin graft

2.2

7.4

265

H02AB04

ATC

methylprednisolone; systemic

1.5

7.4

212

1441

CJB99

NOMESCO Finland

Other operation on lens for secondary cataract

+∞

7.3

3656E

ICD-9 Finland

Glaucoma associated with other ocular disorders[GLAUCOMA POSTTRAUMATICUM]

+∞

7.3

3702

FHL

Trabeculotomy

+∞

7.3

CHB05

NOMESCO Finland

Puncture of anterior chamber of eye to lower intraocular pressure

+∞

7.3

3624

FHL

Extracapsular soft cataract removal

+∞

7.3

S01EX05

ATC

netarsudil; ophthalmic

+∞

7.3

3632A

ICD-9 Finland

Chorioretinal inflammations and scars and other disorders of choroid, Other and unspecified forms of chorioretinitis and retinochoroiditis

+∞

7.3

CGG20

NOMESCO Finland

Epikeratofakia or keratofakia

+∞

7.3

H15.0

ICD-10 Finland

Scleritis

9.4

7.3

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

7.2

336

2510

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.0

7.2

396

C69.3

ICD-10 Finland

Malignant neoplasm: Choroid

15.8

7.2

CJG15

NOMESCO Finland

Extraction of dislocated lens with implantation of artificial lens in anterior chamber and iridectomy or iridotomy

15.8

7.2

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

4.3

7.2

N18

ICPC

Paralysis/weakness

2.6

7.2

156

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

7.2

131

796

S01GX08

ATC

ketotifen; ophthalmic

2.2

7.2

288

SPAT1325

SPAT

Vaccination

1.4

7.2

514

4123

3642

FHL

Anterior vitrectomy

30.1

7.1

7433A

ICD-9 Finland

Congenital anomalies of eye, Congenital cataract and lens anomalies

30.1

7.1

M01CB01

ATC

sodium aurothiomalate; parenteral

3.2

7.1

3661A

ICD-9 Finland

Cataract, Senile cataract

3.0

7.1

101

71200

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis

12.1

7.1

E11.01

ICD-10 Finland

Non-insulin dependent diabetes diabetic coma with hyperglycaemia

12.1

7.1

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

2.5

7.0

182

N02AX02

ATC

tramadol; systemic, rectal

1.3

7.0

669

5590

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

7.0

102

583

N17.8

ICD-10 Finland

Other acute renal failure

3.0

6.9

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

6.9

112

660

S01BC01

ATC

indometacin; ophthalmic

13.8

6.9

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.3

6.9

209

A10BB12

ATC

glimepiride; oral

1.7

6.8

133

823

H52.1

ICD-10 Finland

Myopia

2.4

6.8

191

321

Kela drug reimbursment

Paricalcitol and cinacalcet

4.1

6.8

SPAT1254

SPAT

Administration of medicine

1.5

6.8

245

1744

C07AB07

ATC

bisoprolol; oral

1.3

6.8

824

7107

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.8

6.8

506

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

3.0

6.8

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

6.8

249

C69.39

ICD-10 Finland

Malignant tumor in chorioidea other or unspecified histology

40.2

6.8

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

16.8

6.7

H05BX02

ATC

paricalcitol; systemic

16.8

6.7

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.8

6.7

560

TNG10

NOMESCO Finland

Puncture of knee

3.4

6.7

3619

FHL

Other operations in this group, such as corneal refractive surgery

22.6

6.7

H3603, E119,

ICD-10 Finland

22.6

6.7

CJB30

NOMESCO Finland

Excision of secondary cataract

22.6

6.7

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.5

6.7

201

1380

2500X

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,NUD]

6.4

6.6

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

6.6

148

949

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

6.6

395

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.9

6.6

474

H02.1

ICD-10 Finland

Ectropion of eyelid

3.2

6.6

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.0

6.6

333

N02AA05

ATC

oxycodone; systemic

1.4

6.6

326

2462

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

8.7

6.6

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

6.5

380

2944

H54.6

ICD-10 Finland

Moderate visual impairment, monocular

10.1

6.5

CK2K4

NOMESCO Finland

Red-free imaging of ocular fundus

10.1

6.5

I25.2

ICD-10 Finland

Old myocardial infarction

1.6

6.5

139

881

TQW80

NOMESCO Finland

Local dermatologic skincare

2.4

6.5

189

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.8

6.5

112

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

6.5

294

2185

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.6

6.5

135

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.8

6.5

551

TNX34

NOMESCO Finland

Major custom molded cast, unspecified region

3.1

6.5

3793C

ICD-9 Finland

Other disorders of eye, Aphakia and other disorders of lens[PSEUDOPHAKIA]

6.2

6.5

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.9

6.4

449

H10.5

ICD-10 Finland

Blepharoconjunctivitis

2.9

6.4

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.8

6.4

107

3768

FHL

Eye examination under general anesthesia

70.1

6.4

H21.5

ICD-10 Finland

Other adhesions and disruptions of iris and ciliary body

70.1

6.4

R55

ICD-10 Finland

Syncope and collapse

1.5

6.4

191

1308

K08.3

ICD-10 Finland

Retained dental root

1.7

6.4

124

767

M08.9

ICD-10 Finland

Juvenile arthritis, unspecified

14.4

6.4

H02.0

ICD-10 Finland

Entropion and trichiasis of eyelid

2.3

6.4

191

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

6.3

446

3558

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.7

6.3

116

708

RJ120, ,

NOMESCO Finland

11.1

6.3

3AC01, ,

NOMESCO Finland

3.5

6.3

H10.4

ICD-10 Finland

Chronic conjunctivitis

3.5

6.3

SPAT1153

SPAT

Removal of sutures

1.3

6.3

460

3690

CFC00

NOMESCO Finland

Excision of lesion of conjunctiva

9.3

6.3

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

6.3

266

1952

S05.2

ICD-10 Finland

Ocular laceration and rupture with prolapse or loss of intraocular tissue

18.1

6.3

H40.21

ICD-10 Finland

Intermittent glaucoma with closed ventricular angle

+∞

6.3

CWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in eye and adjacent structures

+∞

6.3

TCG20

NOMESCO Finland

Laser suture lysis in cornea or sclera

+∞

6.3

3627A

ICD-9 Finland

Other retinal disorders, Hereditary retinal dystrophies[DYSTROPHIA RETINAE PIGMENTOSA]

+∞

6.3

37108

ICD-8 Finland

Corneal opacity, Alia definita

+∞

6.3

37601

ICD-8 Finland

Detachment of retina, Secundaria

+∞

6.3

74420

ICD-8 Finland

Congenital anomalies of eye, Buphthalmus (glaucoma)

+∞

6.3

3655A

ICD-9 Finland

Glaucoma associated with disorders of the lens

+∞

6.3

3654A

ICD-9 Finland

Glaucoma associated with congenital anomalies, dystrophies and systemic syndromes

+∞

6.3

36399

ICD-8 Finland

Keratitis, Without mention of ulcer

+∞

6.3

36401

ICD-8 Finland

Iritis, Iridocyclitis glaucomatosa. Syndroma Posner-Schlossman, heterochromia iridis

+∞

6.3

CKD85

NOMESCO Finland

Removal of subretinal membrane or band

+∞

6.3

XQ800

NOMESCO Finland

Prick test

1.8

6.2

483

CJF99

NOMESCO Finland

Other operation on artificial lens

26.8

6.2

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

6.2

250

1817

L04AA24

ATC

abatacept; parenteral

7.0

6.2

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

7.0

6.2

C07AB02

ATC

metoprolol; systemic

1.4

6.2

353

2724

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.2

6.2

245

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.3

6.2

206

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

6.2

484

H66.9

ICD-10 Finland

Otitis media, unspecified

1.9

6.2

419

H47.0

ICD-10 Finland

Disorders of optic nerve, not elsewhere classified

6.3

6.2

R60.0

ICD-10 Finland

Localized oedema

1.5

6.1

202

1412

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

6.1

107

644

R4110

NOMESCO Finland

Physiotherapy

1.3

6.1

415

3292

3639

FHL

Other measure in this category

12.6

6.1

C03DA01

ATC

spironolactone; oral

1.5

6.1

214

1517

C07AB12

ATC

nebivolol; oral

2.2

6.0

215

H20

ICD-10 Finland

Iridocyclitis

6.7

6.0

A12AA12

ATC

[U] calcium acetate

10.1

6.0

WX402

NOMESCO Finland

General anaesthesia

1.4

6.0

292

2194

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

372

1787

2.38

43.40

2.7

1.8

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

267

1196

2.46

35.88

7.4

4.0

136.56

94.50

ng/l

4.18

232

1028

(3014148) Varicella zoster virus Ab [Titer] in Serum

140

5.32

35.39

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

165

596

2.96

33.87

3.0

1.9

40.70

38.89

u/l

0.46

150

530

(3003458) Phosphate [Moles/volume] in Serum or Plasma

401

2187

2.09

33.27

13.7

6.0

1.15

1.04

mmol/l

8.46

375

2024

(40768446) Kidney Pathology biopsy report

9.05

31.64

1.8

1.6

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

927

6747

1.81

31.24

7.5

5.3

34.30

35.05

g/l

3.71

877

6307

(3013115) Eosinophils [#/volume] in Blood

1007

7535

1.81

30.69

10.2

6.4

0.20

0.19

e9/l

0.16

920

6536

(3006315) Basophils [#/volume] in Blood

983

7306

1.80

30.62

10.2

6.2

0.04

e9/l

0.16

903

6231

(3001604) Monocytes [#/volume] in Blood

980

7287

1.80

30.38

10.2

6.2

0.61

0.60

e9/l

0.80

900

6209

(3020779) Urea [Moles/volume] in Serum or Plasma

301

1519

2.19

30.28

16.5

7.5

13.48

10.87

mmol/l

6.82

290

1453

(3019198) Lymphocytes [#/volume] in Blood

994

7451

1.79

29.69

10.2

6.3

1.72

1.91

e9/l

4.27

915

6515

(3042936) Bacteria identified in Isolate by Culture

389

2209

1.98

28.33

3.2

2.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

407

2350

1.96

28.23

5.1

2.7

21.32

22.35

0.99

388

2191

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

9.33

27.43

2.2

2.4

8.75

9.68

mg/l

0.24

(3004789) Transferrin [Mass/volume] in Serum or Plasma

429

2544

1.91

27.37

4.9

2.7

2.13

2.27

g/l

4.90

406

2346

(3013650) Neutrophils [#/volume] in Blood by Automated count

1055

8197

1.74

26.32

12.4

9.5

4.46

4.23

e9/l

2.03

959

7078

(3022948) Iron [Moles/volume] in Serum or Plasma

445

2708

1.87

26.03

5.0

2.7

11.20

12.46

umol/l

4.05

423

2519

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

269

3.52

25.96

2.1

1.4

—

(3035350) Ketones [Presence] in Urine by Test strip

990

7584

1.71

25.75

5.8

4.1

0.06

2.87

estimate

1.04

262

1666

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

110

368

3.12

25.72

2.8

2.1

11.81

12.26

mg/l

0.20

110

339

(40760892) CBC W Ordered Manual Differential panel - Blood

488

3071

1.82

25.54

6.6

4.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

979

7493

1.71

25.40

5.8

4.1

0.00

estimate

0.50

255

1622

(3012516) Albumin [Mass/volume] in Urine

696

4861

1.72

25.32

5.4

3.5

121.06

51.14

mg/l

3.99

519

3220

(3020682) Albumin/Creatinine [Ratio] in Urine

708

4973

1.72

25.19

6.4

4.2

22.75

9.19

mg/mmol

4.14

519

3202

(3009261) Glucose [Presence] in Urine by Test strip

991

7628

1.70

25.00

5.9

4.1

4.40

0.20

estimate

0.47

230

1559

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

274

3.41

24.54

2.0

1.4

—

20.90

—

(3000850) Epithelial cells [#/volume] in Urine

540

3543

1.76

24.33

4.1

2.7

5.19

5.31

e6/l

0.07

501

3241

(3019069) Monocytes/Leukocytes in Blood

898

6783

1.67

23.89

10.3

6.5

8.86

9.00

0.84

867

6347

(3042733) HLA Ab [Presence] in Serum

8.29

23.54

6.0

4.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

307

3.22

23.54

8.7

5.9

720.05

540.00

iu/ml

0.14

(3029937) Albumin [Presence] in Urine by Test strip

619

4252

1.71

23.49

6.1

4.2

0.00

0.01

estimate

1.34

213

1486

(3006504) Eosinophils/Leukocytes in Blood

895

6773

1.67

23.48

10.2

6.4

2.77

2.81

0.25

863

6334

(3022096) Basophils/Leukocytes in Blood

894

6772

1.66

23.30

10.3

6.5

0.66

0.07

863

6326

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

130

4.50

23.25

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

712

5093

1.68

23.11

5.3

3.4

6.64

7.55

mmol/l

7.88

610

4280

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1305

10946

1.78

23.04

11.5

8.3

82.79

80.76

u/l

0.91

1249

10377

(3032080) INR in Blood by Coagulation assay

937

7231

1.65

22.31

20.0

18.1

1.30

1.33

inr

0.69

817

6102

(3002030) Lymphocytes/Leukocytes in Blood

904

6923

1.64

22.11

10.3

6.5

25.41

26.60

2.54

880

6559

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

9.13

22.11

1.1

—

(3026008) Bacteria identified in Urine by Culture

670

4771

1.66

21.77

3.8

3.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

7.50

21.67

1.1

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

138

4.24

21.56

2.3

2.5

28.30

51.82

iu/ml

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

326

1896

1.89

21.51

4.2

4.4

249.78

249.26

u/l

0.02

315

1809

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

241

3.39

21.48

2.1

1.4

174.59

163.15

au/ml

0.41

(3012095) Magnesium [Moles/volume] in Serum or Plasma

413

2588

1.78

21.37

3.7

3.4

0.82

mmol/l

0.21

393

2435

(3021589) Normoblasts [#/volume] in Blood

827

6239

1.62

21.15

19.2

12.0

0.00

e9/l

0.38

727

5067

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

171

788

2.30

21.11

2.2

1.8

1.57

1.53

g/l

0.22

150

693

(3027945) Reticulocytes/Erythrocytes in Blood

336

1984

1.86

21.11

3.4

2.6

1.89

1.80

0.79

318

1772

(3018010) Neutrophils/Leukocytes in Blood

884

6784

1.62

21.03

10.1

6.3

59.47

58.19

2.57

864

6464

(3017143) Hepatitis C virus Ab [Presence] in Serum

264

1443

1.98

20.92

2.6

1.6

—

(42870588) Differential panel, method unspecified - Blood

686

4973

1.63

20.42

10.0

6.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

351

2.90

20.33

3.2

2.3

191.11

96.05

ug/min

1.23

211

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

973

7681

1.61

20.30

13.8

7.6

1.20

1.21

mmol/l

1.58

849

6625

(3002179) Metamyelocytes/Leukocytes in Blood

236

1254

2.02

20.23

4.6

4.4

0.51

0.72

1.03

415

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

119

475

2.62

20.07

5.4

3.9

1.87

1.66

mg/l

1.74

113

422

(3025159) Blasts/Leukocytes in Blood

235

1260

2.00

19.61

5.2

4.8

0.54

0.15

0.42

350

(3028679) Herpes simplex virus Ab [Presence] in Serum

6.06

19.53

1.2

—

(3021440) Promyelocytes/Leukocytes in Blood

235

1263

2.00

19.47

4.9

4.6

0.12

0.11

0.09

383

(3013826) Glucose [Moles/volume] in Serum or Plasma

1077

8761

1.61

19.42

9.1

5.4

7.65

6.78

mmol/l

19.83

1050

8358

(3015736) pH of Urine

800

6077

1.59

19.25

5.2

3.6

6.33

6.24

1.27

438

3405

(3017181) Myelocytes/Leukocytes in Blood

243

1331

1.96

19.05

4.8

4.5

0.66

0.93

1.21

453

(3023520) Reticulocytes [#/volume] in Blood

268

1518

1.91

19.01

3.4

2.7

70.17

69.36

e9/l

0.15

215

1127

(3018418) pH of Serum or Plasma

637

4596

1.61

18.97

9.9

4.2

7.39

7.40

3.51

504

3314

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

785

5951

1.58

18.96

5.3

4.2

132.89

78.40

ng/l

0.32

627

4460

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

109

429

2.64

18.91

1.6

1.5

0.57

0.23

iu/ml

0.47

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

751

5642

1.59

18.81

5.8

4.1

0.50

0.43

estimate

0.05

212

1357

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

590

4196

1.62

18.55

3.0

2.3

3.11

2.94

mg/l

0.94

542

3602

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

826

6383

1.56

18.04

3.3

2.4

76.15

77.92

nmol/l

1.05

748

5694

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

139

3.90

18.03

1.2

1.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1174

9834

1.60

17.96

6.5

4.7

—

2.94

—

(3024471) HLA-A [Type]

7.67

17.85

1.0

—

(3023368) Bacteria identified in Blood by Culture

639

4665

1.59

17.83

6.2

4.4

—

(3002582) Erythrocytes [#/volume] in Urine

681

5054

1.57

17.66

5.0

3.5

166.85

93.21

e6/l

0.40

566

3928

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

299

1811

1.79

16.98

2.4

1.6

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1219

10369

1.60

16.84

6.4

4.3

16.42

13.28

mm/h

8.03

1148

9656

(3018095) Leukocytes [#/volume] in Urine

742

5663

1.54

16.71

6.0

4.1

146.71

117.87

e6/l

0.34

578

4089

(3021447) Carbon dioxide [Partial pressure] in Venous blood

290

1749

1.79

16.69

8.2

3.8

5.91

5.82

kpa

0.87

283

1708

(3021879) Hepatitis B virus core Ab [Presence] in Serum

184

956

2.03

16.67

1.6

1.4

—

(3030467) Casts [#/volume] in Urine by Automated count

596

4335

1.57

16.62

4.7

3.4

0.36

0.49

e6/l

0.78

483

3251

(3003396) Base excess in Arterial blood by calculation

311

1919

1.76

16.53

7.5

7.9

0.38

0.91

mmol/l

1.12

245

1574

(3019309) Folate [Moles/volume] in Red Blood Cells

423

2839

1.65

16.45

1.9

1.8

1276.09

1161.70

nmol/l

1.69

344

2142

(3036481) Cortisol [Moles/volume] in Serum or Plasma

239

1365

1.87

16.40

2.4

2.2

373.09

378.52

nmol/l

0.18

229

1261

(3018677) aPTT in Platelet poor plasma by Coagulation assay

372

2417

1.69

16.39

2.7

2.1

29.69

29.81

0.10

367

2351

(3002032) Base excess in Venous blood by calculation

281

1694

1.79

16.16

9.5

3.8

1.21

1.92

mmol/l

3.42

252

1448

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

237

3.04

16.07

3.6

3.2

256.29

1725.44

u/ml

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

103

428

2.50

15.99

2.1

1.7

—

(3010375) cycloSPORINE [Mass/volume] in Blood

5.77

15.88

26.2

28.5

99.67

129.38

ug/l

1.51

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

868

6906

1.52

15.80

13.1

6.9

1.21

mmol/l

0.30

815

6355

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

311

1944

1.73

15.73

7.6

7.9

5.01

5.10

kpa

0.84

299

1864

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

6.94

15.71

3.3

4.5

11.44

8.52

mg/l

0.30

(3027801) Oxygen [Partial pressure] in Arterial blood

311

1945

1.73

15.70

7.6

7.9

11.81

11.87

kpa

0.07

298

1867

(3031040) Bacteria [#/volume] in Urine by Automated count

1132

9538

1.54

15.65

6.4

5.1

359.53

1941.88

e6/l

1.84

162

(3019977) pH of Arterial blood

309

1931

1.73

15.64

7.7

8.0

7.40

7.42

1.63

194

1084

(3012544) pH of Venous blood

287

1760

1.76

15.52

8.2

3.8

7.37

7.38

2.03

206

1052

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

958

7807

1.51

15.37

6.5

6.7

11.51

12.06

umol/l

0.49

919

7452

(3016502) Oxygen saturation in Arterial blood

283

1735

1.75

15.30

7.8

8.2

94.99

95.26

0.29

274

1678

(3035715) Granulocytes [#/volume] in Blood

255

2.90

15.28

3.9

3.2

4.71

4.37

e9/l

0.33

255

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

263

1580

1.78

15.25

4.0

3.7

—

(3024354) Oxygen [Partial pressure] in Venous blood

249

1473

1.81

15.20

6.4

3.3

4.54

4.51

kpa

0.11

242

1439

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

633

4744

1.53

15.07

3.5

3.3

36.00

33.61

u/l

0.21

602

4485

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

627

4698

1.52

14.91

4.5

2.6

68.85

78.30

u/l

0.21

586

4363

(3020630) Protein [Mass/volume] in Serum or Plasma

236

1388

1.81

14.66

2.3

2.9

66.88

66.29

g/l

0.54

219

1273

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

657

4992

1.51

14.52

3.8

3.4

2861.01

1801.00

ng/l

3.11

574

4319

(3008898) HLA-B27 [Presence]

419

2.42

14.32

1.2

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

4.44

14.29

1.1

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

260

1587

1.75

14.21

8.5

8.8

115.87

120.63

g/l

3.11

255

1548

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

123

583

2.19

14.14

3.7

2.7

0.31

0.37

iu/ml

0.95

321

(3024932) HLA-DR beta [Type]

6.74

14.04

1.1

1.2

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

624

4717

1.51

14.01

2.4

2.2

170.09

247.90

u/l

1.65

595

4474

(3037522) Nuclear Ab [Titer] in Serum

292

1856

1.69

13.76

1.5

1.3

802.78

455.15

titre

1.28

404

(3005719) IgG [Mass/volume] in Serum or Plasma

192

1092

1.85

13.25

2.9

11.56

10.77

g/l

0.68

177

1012

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

259

2.73

13.18

1.5

1.2

264.17

271.04

u/ml

0.07

138

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1484

13500

1.70

13.14

28.9

18.1

24.51

26.62

mg/l

1.72

1300

11362

(3026782) Osmolality of Urine

436

3106

1.54

12.72

4.1

3.1

506.42

538.48

mosm/kgh2o

2.65

392

2731

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

12.36

12.61

10.0

14.7

5.77

5.42

mmol/l

0.10

(3027273) Bicarbonate [Moles/volume] in Venous blood

147

780

1.97

12.51

5.6

3.3

24.55

25.14

mmol/l

1.08

142

758

(3011397) Hemoglobin [Presence] in Urine by Test strip

475

3475

1.51

12.14

6.1

3.8

0.40

0.08

—

(3020876) Protein [Mass/time] in 24 hour Urine

191

2.94

12.14

2.8

2.4

1.95

1.34

g/24h

0.60

111

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

229

1408

1.72

12.11

2.7

2.5

6.98

7.24

ug/l

0.04

201

1243

(3000991) Gas panel - Venous blood

235

1469

1.69

11.68

13.2

8.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

4.63

11.66

1.0

1957.63

1430.39

miu/ml

1.49

(3015377) Calcium [Moles/volume] in Serum or Plasma

660

5196

1.44

11.43

4.0

3.5

2.33

2.35

mmol/l

2.71

618

4691

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

110

543

2.10

11.42

1.4

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1505

13858

1.66

11.30

34.3

21.8

139.28

139.58

mmol/l

4.15

1481

13579

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

4.11

11.15

1.9

2.7

570.80

1309.55

u/ml

1.34

(3023103) Potassium [Moles/volume] in Serum or Plasma

1505

13879

1.65

10.97

35.1

22.0

4.02

3.99

mmol/l

2.11

1480

13578

(3028626) Oxygen [Partial pressure] in Capillary blood

451

2.17

10.91

3.7

3.6

8.31

8.05

kpa

0.77

441

(3008152) Bicarbonate [Moles/volume] in Arterial blood

172

1007

1.79

10.76

8.9

7.1

23.70

24.37

mmol/l

1.29

165

963

(1616796) Gas panel - Central venous blood

363

2.29

10.69

6.0

4.1

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1241

11006

1.45

10.67

33.9

22.2

13.95

13.78

4.06

1235

10863

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

188

1133

1.74

10.65

3.6

3.0

53.41

62.82

ml/min/173m2

2.70

498

(3028026) IgM [Mass/volume] in Serum or Plasma

153

872

1.83

10.46

1.8

1.57

1.42

g/l

0.24

137

806

(3035933) Granulocytes/Leukocytes in Blood

322

2.36

10.46

4.1

3.1

59.69

58.83

0.21

322

(3041096) Erythrocytes [Presence] in Urine by Automated

523

3996

1.44

10.44

4.6

3.6

0.26

0.05

estimate

0.38

196

1275

(40767503) Oxygen content in Capillary blood by calculation

331

2.32

10.27

3.3

2.7

15.69

16.01

0.36

325

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

435

3220

1.47

10.22

2.0

1.8

61308332.52

19408449.69

pmol/l

0.60

367

2669

(46235355) HIV 1 and 2 tests - Meaningful Use set

310

2156

1.53

9.83

2.6

1.8

—

(3000494) Fungus identified in Specimen by Culture

259

1739

1.58

9.59

1.7

1.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

788

6535

1.38

9.56

4.8

3.1

161.11

139.97

ug/l

1.56

739

6049

(3014111) Lactate [Moles/volume] in Serum or Plasma

230

1508

1.61

9.41

9.4

7.8

1.35

1.37

mmol/l

0.10

225

1479

(3017732) Neutrophils [#/volume] in Blood

260

1759

1.56

9.30

3.3

4.58

4.97

e9/l

0.33

232

1513

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

233

2.50

9.26

1.2

1.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1530

14287

1.62

9.18

36.2

23.6

98.62

81.87

umol/l

13.95

1513

14087

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

183

1141

1.68

9.13

5.1

4.0

5.04

5.15

kpa

0.91

176

1086

(3021960) Folate [Moles/volume] in Serum or Plasma

568

4490

1.39

9.10

1.9

1.7

20.86

19.84

nmol/l

0.64

497

3788

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

285

2.33

9.07

1.4

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

11.52

9.07

1.1

1.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

419

3149

1.44

8.93

1.9

1.8

1.39

1.33

mg/l

0.20

348

2454

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

385

2850

1.45

8.89

2.2

2.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

4.36

8.87

2.6

2.7

0.62

0.61

mmol/l

0.32

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

186

1178

1.65

8.74

2.0

1.7

—

(3009343) pH of Capillary blood

177

1114

1.66

8.52

5.2

4.1

7.40

7.41

3.08

153

944

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

301

2.24

8.42

9.3

1.7

0.82

0.89

nmol/l

0.39

255

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

796

6712

1.34

8.25

2.4

2.2

96.24

94.26

pmol/l

0.52

452

3681

(3036489) Thrombin time

526

1.91

8.11

2.3

2.1

20.87

21.01

0.11

484

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

521

1.91

8.01

3.0

3.5

11.46

5.10

ratio

0.31

313

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

104

572

1.87

7.99

2.9

3.7

69.58

75.28

mg/l

0.07

492

(3034860) Kappa light chains.free [Mass/volume] in Serum

104

572

1.87

7.99

2.9

3.7

87.85

61.72

mg/l

0.59

490

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1179

0.46

7.94

2.2

2.0

3.20

3.50

ratio

1.70

942

(3045414) Leukocytes [Presence] in Urine

208

1385

1.57

7.94

2.3

2.1

0.00

0.02

estimate

0.78

281

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

121

2.93

7.88

1.5

1.6

—

(3021901) Oxygen saturation in Capillary blood

370

2.07

7.87

3.9

2.9

90.82

89.06

1.85

358

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

409

2.00

7.63

1.5

1.7

—

(40761536) Microorganisms panel - Urine sediment

178

1154

1.60

7.61

5.7

4.2

—

(3019150) Specific gravity of Urine by Refractometry

435

3373

1.39

7.59

6.6

4.2

1.02

kg/l

1.11

314

2275

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1499

14054

1.50

7.49

18.7

12.4

25.37

26.02

u/l

0.69

1462

13641

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

406

3120

1.39

7.45

3.3

3.1

2.46

mmol/l

0.41

366

2793

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

241

1682

1.50

7.41

13.7

8.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

3.29

7.39

1.7

2.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

414

1.98

7.38

1.7

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

196

2.44

7.38

1.5

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

553

1.84

7.27

1.4

1.3

—

(3004775) Volume in Urine collected for unspecified duration

116

2.88

7.23

3.3

2.2

692.00

657.29

0.14

(3048929) Epstein Barr virus Ab [Presence] in Serum

397

1.98

7.19

1.5

1.3

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

170

1105

1.60

7.19

10.2

9.5

1.36

1.31

0.22

170

1097

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

405

1.97

7.14

1.9

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

278

2011

1.46

7.13

2.1

1.9

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1349

12441

1.38

7.08

6.2

5.2

1.97

1.98

mu/l

0.03

1247

11412

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

292

2140

1.44

6.98

2.1

1.9

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

3.08

6.90

1.4

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

181

1210

1.55

6.78

8.0

4.0

1.22

mmol/l

0.61

163

1037

(3019832) Treponema pallidum Ab [Presence] in Serum

154

992

1.61

6.77

1.7

—

(3014007) Fractional oxyhemoglobin in Arterial blood

167

1097

1.58

6.76

10.4

9.7

93.49

93.69

0.16

167

1091

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

296

2.10

6.73

1.4

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

6.45

6.64

1.1

1.0

—

(40758558) Short blood count panel - Blood

524

4257

1.33

6.62

8.3

6.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

279

2.12

6.55

1.2

488.00

261.90

titre

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

153

992

1.59

6.55

4.9

3.9

1.32

1.85

mmol/l

0.63

101

727

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

268

2.13

6.42

1.5

1.8

—

(3007461) Platelets [#/volume] in Blood

1534

14533

1.49

6.41

42.9

27.1

249.25

244.90

e9/l

1.67

1512

14218

(3024731) MCV [Entitic mean volume] in Red Blood Cells

1534

14534

1.49

6.40

42.7

27.0

91.76

91.37

2.48

1519

14351

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

118

721

1.68

6.39

2.0

1.9

3.19

2.21

ug/l

0.31

108

634

(3007164) IgA [Mass/volume] in Serum or Plasma

350

2686

1.38

6.38

1.6

1.5

2.58

2.53

g/l

0.16

237

1642

(3026361) Erythrocytes [#/volume] in Blood

1534

14537

1.49

6.36

42.8

27.1

4.34

4.44

e12/l

10.96

1504

14180

(3035941) MCH [Entitic mass]

1534

14537

1.49

6.36

42.7

27.0

30.37

0.05

1519

14352

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

1534

14537

1.49

6.36

43.8

27.7

39.16

40.26

2.79

1520

14345

(3026493) Urate [Moles/volume] in Serum or Plasma

485

3918

1.33

6.32

3.5

2.9

370.08

354.84

umol/l

1.98

419

3426

(3010813) Leukocytes [#/volume] in Blood

1534

14540

1.49

6.32

42.9

27.1

7.02

6.89

e9/l

1.31

1507

14176

(3000963) Hemoglobin [Mass/volume] in Blood

1534

14541

1.49

6.31

43.2

27.3

130.51

133.85

g/l

12.76

1522

14360

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

9.29

6.29

1.0

2.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1146

10385

1.31

6.29

5.0

4.2

15.17

14.91

pmol/l

2.53

1035

9461

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

346

1.97

6.27

1.4

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

319

2.01

6.23

1.8

1.4

174.14

677.17

e6/l

0.74

245

(40761511) CBC panel - Blood by Automated count

1461

13732

1.41

6.22

25.9

16.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

155

1023

1.57

6.15

8.6

9.5

23.59

24.29

mmol/l

1.73

149

994

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1361

12652

1.36

6.15

10.0

6.7

44.95

39.78

mmol/mol

33.02

1262

11779

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

143

927

1.59

6.13

9.0

10.8

15.36

15.78

1.03

137

892

(1175426) CD3 cells/Lymphocytes in Blood

2.98

6.12

1.7

2.1

72.73

72.90

0.02

(21494815) CD4 cells/Lymphocytes in Specimen

105

2.79

6.06

1.4

2.0

38.66

38.69

0.00

105

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.95

6.01

1.4

1.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

236

1709

1.44

5.99

2.9

2.8

7.07

8.66

umol/l

0.71

199

1518

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

857

0.45

5.98

1.8

3.30

3.46

mmol/l

0.41

620

(21494814) CD8 cells/Lymphocytes in Specimen

3.81

5.81

1.5

1.9

29.41

32.80

0.37

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

6.13

5.69

1.5

1.1

96.91

142.49

ng/l

—

(3043409) Potassium [Moles/volume] in Arterial blood

449

1.80

5.55

6.8

4.0

4.04

3.93

mmol/l

1.09

444

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

299

1.97

5.49

1.4

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

407

1.83

5.46

1.5

1.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

335

1.91

5.45

1.2

1.3

139.19

233.95

miu/ml

0.73

151

(3012501) Base excess in Blood by calculation

321

1.93

5.44

7.0

5.2

2.54

2.74

mmol/l

0.24

224

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

116

737

1.62

5.43

4.3

5.4

1.51

1.54

0.18

109

695

(3006184) Hemoglobin [Mass/volume] in Capillary blood

401

1.83

5.41

2.7

2.2

123.41

128.57

g/l

0.81

320

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1371

12834

1.33

5.36

27.4

17.5

72.70

77.36

ml/min/173m2

9.84

1310

11954

(3026389) Candida sp identified in Specimen by Organism specific culture

155

2.35

5.35

1.4

—

(3028433) Virus identified in Specimen by Culture

3.57

5.33

1.2

1.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

125

813

1.58

5.31

1.3

57.80

53.90

au/ml

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

317

1.92

5.30

1.8

1.3

31.39

58.22

e6/l

0.37

233

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

313

1.92

5.16

1.9

2.2

3133.97

5285.04

u/l

0.30

125

(21494755) Public health laboratory ask at order entry panel

949

0.52

5.07

1.3

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

128

2.45

5.06

1.5

1.3

6.66

6.80

g/l

0.07

(3047181) Lactate [Moles/volume] in Blood

463

1.74

5.03

4.8

7.0

1.22

1.36

mmol/l

1.05

406

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

133

890

1.54

5.00

2.4

2.5

48.36

19.53

au/ml

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

248

2.00

4.91

1.4

1.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

339

2689

1.32

4.88

4.0

3.1

0.89

1.28

e6/l

1.05

198

1446

(3025941) Bacteria identified in Stool by Culture

109

701

1.59

4.88

1.5

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

206

1511

1.41

4.86

2.2

2.3

0.19

0.20

g/l

1.05

193

1401

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

9.04

4.78

1.2

2.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

190

2.13

4.75

1.2

1.3

2.95

4.78

u/ml

0.34

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.43

4.75

3.5

2.8

5.08

4.80

kpa

0.67

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.43

4.75

3.5

2.8

10.47

10.11

kpa

0.18

(4195642) Thrombophilia screening test

164

2.22

4.73

1.3

—

(3000012) Reticulocyte production index

252

1.97

4.71

2.1

0.95

0.87

0.57

178

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

178

2.16

4.67

1.5

1.8

—

2306.67

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

103

2.55

4.64

1.4

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

470

3917

1.27

4.64

4.0

3.2

0.13

0.05

0.24

117

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

575

1.63

4.63

2.6

—

(3016750) Collection duration of Urine

2.70

4.59

3.7

2.2

499.63

508.88

min

0.23

(3024139) IgG subclass 3 [Mass/volume] in Serum

128

2.37

4.59

1.5

1.3

0.39

0.45

g/l

0.31

(3028192) IgG subclass 2 [Mass/volume] in Serum

128

2.37

4.59

1.5

1.3

2.77

2.92

g/l

0.17

(3023420) DNA double strand Ab [Units/volume] in Serum

539

1.65

4.54

1.9

1.7

3.70

6.61

iu/ml

1.09

125

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

187

2.11

4.53

1.2

1.3

2.12

6.06

u/ml

1.83

(3045424) Erythrocytes [Presence] in Urine

109

714

1.56

4.53

2.4

2.2

0.00

1.20

estimate

0.50

210

(3017569) Oxygen content in Arterial blood

2.60

4.48

1.8

2.8

15.40

16.26

0.61

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

764

6752

1.24

4.46

3.8

2.9

—

estimate

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

497

1.66

4.40

1.4

1.2

0.35

1.09

u/ml

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

102

663

1.57

4.39

4.8

5.8

0.82

0.85

0.37

625

(3037756) Immunofixation for Serum or Plasma

354

1.78

4.35

1.3

1.7

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

8.92

4.28

1.0

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

219

1.99

4.28

1.3

1.4

1330.03

1521.05

e6/l

0.15

153

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

368

3004

1.29

4.25

1.5

1.3

1.17

1.39

u/ml

0.27

118

795

(4062490) Immunoglobulin typing, IgG

128

2.29

4.14

1.6

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

460

1.66

4.10

1.5

251.56

278.66

ug/g

0.52

276

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

203

1.99

4.03

1.4

1.6

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

5.58

3.97

1.2

82.10

95.00

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

191

2.01

3.94

1.3

1.4

16014.85

49675.83

e6/l

1.02

109

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

189

1418

1.37

3.92

4.3

2.4

42.81

38.39

u/l

0.20

155

1188

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

366

3018

1.27

3.87

5.0

4.2

210.03

359.13

ng/l

0.90

315

2485

(3020911) Cortisol [Moles/time] in 24 hour Urine

3.96

3.79

1.1

1.9

71.31

105.03

nmol/24h

0.57

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

2.58

3.72

1.8

2.2

483.14

619.06

e6/l

0.50

(3024980) IgG subclass 4 [Mass/volume] in Serum

225

1.89

3.66

1.5

1.6

0.42

0.83

g/l

2.97

177

(3047189) Immunofixation for 24 hour Urine

2.55

3.63

1.7

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

287

1.76

3.51

1.9

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

340

1.70

3.50

1.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

172

2.00

3.50

2.1

2.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1394

13276

1.26

3.49

6.9

5.9

2.41

2.61

mmol/l

14.55

1296

12240

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

173

1.98

3.45

1.3

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

7.02

3.36

4.0

4.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

127

2.14

3.36

1.1

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

2.38

3.32

1.2

1.1

36.91

40.46

mg/l

0.20

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

2.55

3.30

1.2

1.0

1.07

1.24

u/l

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

8.60

3.26

1.3

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.35

3.22

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1366

13026

1.23

3.11

6.1

5.1

4.27

4.50

mmol/l

13.39

1269

12070

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

408

1.59

3.07

1.5

1.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

7.52

3.05

2.7

3.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

118

856

1.41

3.04

1.7

1.5

—

(3025549) Creatine [Moles/time] in 24 hour Urine

5.85

3.02

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1356

12936

1.22

2.99

6.0

5.0

1.39

1.43

mmol/l

2.19

1253

11902

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

2.84

2.92

1.1

—

14.56

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

110

796

1.41

2.88

4.2

3.5

4.35

4.47

pmol/l

0.56

102

703

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

5.40

2.87

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

3.17

2.85

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

3.17

2.85

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

3.17

2.85

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

3.17

2.85

1.2

1.1

—

(3004451) EKG impression Narrative

109

2.13

2.85

1.4

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

393

1.57

2.83

1.2

93.33

105.00

titre

—

(3003181) Sodium [Moles/volume] in Urine

315

1.64

2.81

1.3

53.38

61.75

mmol/l

0.88

255

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.59

2.78

1.2

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

8.35

2.75

5.8

5.2

509.80

387.67

umol/l

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

485

1.51

2.74

2.7

2.6

0.00

g/l

-0.00

423

(3023183) Ammonium ion [Moles/volume] in Plasma

349

1.59

2.73

1.9

2.8

31.14

32.59

umol/l

0.13

305

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

342

1.60

2.70

2.0

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.01

2.69

1.3

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.46

2.69

70.1

8.1

7.64

5.30

kpa

—

(3016018) Differential panel - Cerebral spinal fluid

147

1.92

2.66

2.5

1.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.16

2.61

3.5

1.8

106.05

100.30

ng/l

0.16

(3045788) Cell count panel - Pleural fluid

177

1.82

2.60

1.3

1.4

—

(3042631) Mycobacterium sp identified in Specimen

214

1.74

2.60

2.3

2.7

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

163

1.86

2.58

1.7

1.3

—

nmol/l

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

601

1.44

2.56

2.5

2.7

11.35

10.45

g/l

0.71

534

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.14

2.55

1.0

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

357

1.56

2.50

2.7

1.9

2.95

20.66

iu/l

0.53

138

(3000093) Morphology [Interpretation] in Blood Narrative

144

1.89

2.47

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

423

3699

1.19

2.46

3.5

2.5

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

130

1.94

2.46

1.4

1.5

43.67

30.36

0.60

(3006571) Granulocytes/Leukocytes in Synovial fluid

166

1.82

2.45

1.5

1.6

39.20

61.62

1.88

111

(3006245) CD3-CD19+ cells/cells in Blood

2.68

2.45

2.6

2.3

6.75

8.74

0.35

(3039443) Prostate specific Ag panel - Serum or Plasma

254

0.39

2.44

1.2

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

547

4894

1.17

2.42

3.5

2.6

—

(40768797) Stomach Pathology biopsy report

236

1954

1.24

2.40

1.3

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

167

1328

1.29

2.38

3.2

3.3

308.09

240.54

ng/l

0.81

154

1221

(3048689) Calprotectin [Mass/mass] in Stool

203

1654

1.26

2.38

2.5

2.4

186.07

128.56

ug/g

0.74

156

1331

(3044242) Glucose [Moles/volume] in Arterial blood

111

1.99

2.36

1.5

2.3

9.36

8.01

mmol/l

0.66

111

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

496

1.45

2.31

2.7

2.5

0.00

0.02

g/l

0.99

444

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

119

1.95

2.31

2.2

1.1

106.91

105.92

pmol/l

0.03

119

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

223

1.67

2.28

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1295

12400

1.18

2.27

5.2

4.3

1.32

1.29

mmol/l

0.83

1183

11300

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

685

1.38

2.25

2.4

2.6

3.88

3.68

g/l

0.44

621

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

686

1.38

2.24

2.4

2.6

4.17

4.18

g/l

0.06

623

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

686

1.38

2.24

2.4

2.6

7.69

7.41

g/l

1.01

622

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1160

11017

1.16

2.24

36.5

23.3

330.73

331.90

g/l

3.96

1152

10940

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

295

2520

1.21

2.21

4.3

3.2

2.04

2.28

e6/l

0.19

153

1277

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

349

0.51

2.19

1.6

1.1

0.51

0.66

ratio

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

586

1.40

2.19

2.7

1.40

1.28

g/l

0.07

502

(3012441) Differential panel - Pleural fluid

188

1.72

2.18

1.5

—

(3018572) Chloride [Moles/volume] in Blood

322

1.54

2.15

6.0

8.3

104.18

105.42

mmol/l

1.11

289

(3039000) Anion gap in Blood by calculation

322

1.54

2.15

6.0

8.3

11.57

11.31

mmol/l

0.21

289

(3001019) Free T4 and TSH panel - Serum or Plasma

510

0.60

2.14

1.6

1.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

174

1.74

2.14

1.2

1.5

19.50

31.84

ng/l

1.06

174

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

168

1.74

2.08

5.9

2.9

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.91

2.07

2.4

1.2

—

(44806420) Estimation of glomerular filtration rate

126

1.84

1.98

2.0

2.5

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

2.15

1.98

1.5

1.1

0.52

0.49

ratio

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

745

1.33

1.98

2.7

2.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

445

1.43

1.97

1.5

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

2.03

1.95

1.1

1.0

—

(3026480) Teichoate Ab [Titer] in Serum

4.56

1.94

1.0

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.97

1.93

1.0

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

2.12

1.92

1.9

1.8

—

36.67

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.09

1.86

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

640

1.35

1.84

2.5

2.6

3.13

2.98

g/l

0.70

576

(3037121) Protein [Mass/volume] in Urine

571

1.36

1.84

4.0

3.5

631.14

374.62

mg/l

0.63

242

(3000475) Leukocytes [#/volume] in Synovial fluid

394

1.44

1.81

1.7

1.6

7625.22

17643.29

e6/l

1.77

276

(3050129) First trimester maternal screen panel - Serum or Plasma

233

0.47

1.78

1.4

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

217

1.58

1.74

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

163

1.67

1.72

3.6

4.8

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.11

1.65

1.2

272.88

232.70

iu/ml

0.12

(4268621) Lupus anticoagulant assay

135

1.71

1.62

2.2

2.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

278

1.49

1.62

1.2

36.05

50.46

u/ml

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

821

7716

1.12

1.61

2.9

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.01

1.58

1.2

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.01

1.58

1.2

1.1

—

(3022313) Gas panel - Capillary blood

783

1.28

1.55

5.7

4.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

122

1.73

1.54

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.43

1.54

1.0

1.1

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

130

1.70

1.53

1.6

1.7

—

(3027944) Amphetamines [Presence] in Urine

394

0.63

1.52

3.2

1.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

591

1.32

1.51

2.1

1.9

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1335

12940

1.14

1.49

5.8

5.3

6.64

6.01

mmol/l

19.93

1215

11776

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

2.08

1.49

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

101

1.79

1.49

3.0

2.0

—

(3002619) Bacteria identified in Specimen by Culture

2.44

1.48

1.0

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

378

0.63

1.46

1.5

1.2

1.52

1.53

g/l

0.12

378

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

622

1.30

1.44

6.1

4.5

23.50

24.86

mmol/l

2.90

572

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.12

1.44

1.2

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.73

1.43

1.0

1.5

—

(4146454) Self-monitoring of blood glucose

165

1.58

1.40

3.8

2.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

360

0.63

1.38

1.4

1.6

869.22

977.60

mu/l

0.34

303

(3051387) C reactive protein [Mass/volume] in Capillary blood

323

1.40

1.37

3.8

32.43

28.41

mg/l

0.26

235

(3052851) Hemolysis interference index of Serum or Plasma

435

1.34

1.36

3.7

3.6

4.14

2.02

index

0.58

234

(1761482) Bacteria [#/volume] in Urine by Culture

392

1.36

1.35

5.0

4.8

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

290

1.42

1.35

1.4

—

(40768806) Pleura Pathology biopsy report

183

1.54

1.35

1.5

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

638

1.28

1.34

2.3

2.0

—

(3049717) Cytology report of Urine Cyto stain

666

1.27

1.33

2.6

2.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

105

855

1.24

1.33

1.3

146.32

225.59

u/ml

0.58

100

792

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.78

1.28

1.2

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

115

1.66

1.25

4.8

5.8

231.63

58.94

u/ml

—

(3022145) Colonoscopy Study observation

182

1578

1.17

1.21

1.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

942

9007

1.10

1.21

3.7

3.4

55.30

52.06

u/l

0.43

876

8416

(3003327) Ova and parasites identified in Stool by Light microscopy

435

1.32

1.21

1.6

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.73

1.21

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.73

1.21

1.2

—

(3027008) Opiates [Presence] in Urine

395

0.68

1.20

3.1

1.9

—

(3017704) Immunofixation for Urine

101

1.69

1.20

1.2

1.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

384

1.34

1.19

1.3

1.2

—

(3016879) Cocaine [Presence] in Urine

370

0.67

1.18

3.2

1.9

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

133

1.59

1.17

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.06

1.15

1.0

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

150

1.54

1.14

1.7

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

388

1.32

1.12

1.3

1.2

—

(4034850) Laboratory test

433

1.30

1.11

23.8

11.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

152

1756

0.85

1.10

6.0

4.9

32.65

32.74

0.03

100

1147

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.82

1.09

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

185

1.47

1.08

1.3

1.4

7.11

6.35

mmol/l

0.64

177

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

2.19

1.08

2.6

1.8

1.20

1.22

mmol/l

—

(3028300) Cannabinoids [Presence] in Urine

397

0.70

1.08

3.1

1.9

—

(3022621) pH of Urine by Test strip

133

1137

1.18

1.07

3.0

2.8

6.18

6.10

0.53

103

789

(3018333) Ribosomal P Ab [Presence] in Serum

1.66

1.06

1.2

1.1

—

(40768804) Tissue Pathology biopsy report

582

5467

1.10

1.06

2.3

2.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

105

1.63

1.06

1.2

1.1

—

(21494434) Karyotype in Bone marrow

145

1.52

1.06

1.0

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

395

0.70

1.05

3.0

1.9

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

266

2397

1.13

1.05

1.4

1.3

49.50

32.10

iu/ml

0.60

737

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.71

1.05

3.4

3.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

128

1093

1.18

1.05

2.0

1.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

393

1.31

1.04

1.3

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.06

1.03

3.4

1.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

360

1.31

1.01

1.3

1.2

2.97

10.20

u/ml

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

360

1.31

1.01

1.3

1.2

1.59

3.59

u/ml

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

172

1.46

1.00

1.0

1.1

1.43

2.19

eliau/ml

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

206

1.41

0.99

1.7

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

0.00

0.97

0.0

3.7

—

42.08

—

(3034426) Prothrombin time (PT)

1.95

0.97

1.0

1.4

26.00

28.72

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.95

0.97

1.3

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

100

1.61

0.96

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

100

1.61

0.96

1.2

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

422

0.73

0.96

1.6

1.9

46.45

39.80

nmol/l

0.81

404

(3020491) Glucose [Moles/volume] in Blood

101

1.59

0.93

1.8

2.5

8.05

6.83

mmol/l

0.60

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

109

1.57

0.93

1.2

1.1

—

(3023410) Appearance of Cerebral spinal fluid

150

1.47

0.93

3.0

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.73

0.92

1.1

1.4

177.22

191.61

mmol/24h

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

491

1.25

0.92

1.3

1.4

29.43

25.59

iu/l

0.36

420

(40768443) Skin Pathology biopsy report

627

1.22

0.92

1.3

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

134

1.50

0.91

1.4

—

(3024263) Appearance of Synovial fluid

1.67

0.91

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

306

1.31

0.89

1.3

21.39

40.30

u/l

1.39

262

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

169

0.59

0.88

1.6

1.7

—

(4024509) Urine culture

667

1.21

0.88

2.2

2.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.65

0.88

1.1

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

574

5431

1.09

0.87

2.4

1.9

1.33

1.34

mmol/l

0.19

480

4567

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

835

1.18

0.86

1.1

1.2

146.80

144.95

u/ml

0.01

321

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

333

0.72

0.86

1.8

1.9

189.42

210.67

pmol/l

0.73

313

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.63

0.84

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

104

1.54

0.84

1.2

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

104

1.54

0.84

1.6

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

104

1.54

0.84

1.2

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

121

1.49

0.82

1.2

—

(4035726) Immunohistochemistry procedure

140

1232

1.15

0.82

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

197

1.38

0.82

1.7

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

105

1.53

0.81

1.6

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

198

1.37

0.80

1.7

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

122

1.48

0.80

1.2

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

212

0.66

0.80

1.2

1.6

98.22

60.60

ug/l

—

182

(3003694) ABO and Rh group [Type] in Blood

407

3810

1.09

0.80

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

199

0.65

0.78

1.2

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

199

1.36

0.78

1.7

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

124

0.56

0.77

1.3

1.6

60.09

52.48

ug/l

—

124

(3009466) Valproate [Moles/volume] in Serum or Plasma

218

1.34

0.75

2.0

5.3

279.17

352.43

umol/l

2.27

196

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.65

0.75

1.1

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

158

1.40

0.74

1.5

1.9

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.09

0.74

1.2

1.3

1.20

1.16

mmol/l

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

361

1.25

0.73

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

361

1.25

0.73

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

569

5418

1.07

0.73

5.4

5.6

2.82

4.02

ug/l

0.73

511

4862

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

125

1.44

0.72

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.61

0.72

1.7

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.61

0.72

1.7

2.1

—

(3006270) Folate [Moles/volume] in Blood

117

1.46

0.71

1.2

460.25

357.94

nmol/l

0.91

100

(3042111) Morphology [Interpretation] in Bone marrow Narrative

264

1.29

0.71

1.9

1.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.55

0.69

1.7

2.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

142

0.63

0.69

1.6

1.5

14.09

25.50

u/l

—

120

(3025130) Human papilloma virus identified in Specimen

145

0.62

0.69

3.1

1.8

—

(3014891) Appearance of Pleural fluid

1.85

0.68

1.2

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

144

1.39

0.68

1.5

1.9

—

(44790047) Parainfluenza type 1 nucleic acid detection

205

1.32

0.67

1.6

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

205

1.32

0.67

1.6

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

205

1.32

0.67

1.6

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

205

1.32

0.67

1.6

1.5

—

(3018133) Calcium [Moles/volume] in Urine

1.79

0.66

1.6

2.2

2.48

3.85

mmol/l

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

103

1.46

0.65

1.5

1.3

7.89

9.11

mmol/l

0.58

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

1.48

0.64

2.4

2.7

44.44

36.76

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.48

0.64

1.1

1.2

—

(40768800) Prostate Pathology biopsy report

359

0.78

0.63

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.52

0.62

1.5

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.52

0.62

1.5

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.52

0.62

1.5

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.52

0.62

1.5

1.9

—

(4133840) Spirometry

1.67

0.61

1.0

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.46

0.61

2.0

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.46

0.61

2.0

1.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

601

1.17

0.61

1.3

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

0.60

0.0

1.3

—

69.05

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.00

0.60

0.0

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

353

1.22

0.60

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.60

0.0

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

150

0.66

0.58

1.9

1.8

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

168

1538

1.10

0.56

1.4

1.8

1.60

1.52

0.56

147

1328

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.58

0.54

1.0

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.49

0.53

1.6

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.49

0.53

1.6

1.3

—

(40768441) Liver Pathology biopsy report

108

1.39

0.53

1.2

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

178

1.30

0.53

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

555

1.16

0.52

1.7

2.1

—

(3004616) Nuclear Ab [Presence] in Serum

161

1.31

0.51

1.2

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.50

0.51

1.3

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

168

0.71

0.50

1.2

1.6

—

(3022689) Creatine [Moles/volume] in Urine

1.46

0.50

1.3

1.6

6.20

7.77

mmol/l

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

312

0.80

0.49

2.7

1.8

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.56

0.49

1.0

1.1

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

145

1.31

0.49

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

111

0.63

0.48

1.0

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

214

1999

1.08

0.48

1.4

1.5

—

(3019225) pH of Specimen

158

1458

1.09

0.47

7.7

4.6

7.37

7.36

0.23

120

1062

(3023430) Cat dander IgE Ab [Units/volume] in Serum

137

1.32

0.47

1.1

1.46

5.85

u/ml

—

(1002224) Polysomnography panel

548

0.85

0.47

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

468

1.16

0.46

1.7

2.0

—

(3006653) Thiamine [Moles/volume] in Blood

1.43

0.45

1.1

1.2

149.18

138.86

nmol/l

0.28

(3023419) Bacteria identified in Sputum by Culture

219

1.24

0.45

1.9

2.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.40

0.45

1.3

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

163

0.73

0.43

1.2

1.5

—

(3014271) Vancomycin [Susceptibility]

1.38

0.42

5.1

3.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.56

0.42

1.0

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

149

1.28

0.42

1.4

1.3

4998.64

165343.08

e6/l

1.49

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.00

0.41

0.0

1.6

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.41

0.0

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

8.06

—

(3005033) Fetal Nuchal fold Thickness US

161

0.74

0.41

1.2

1.5

1.29

1.30

—

119

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.40

0.0

1.0

—

(3051651) Icteric interference index of Serum or Plasma

1.37

0.40

3.8

4.1

0.67

0.92

index

0.89

(40768793) Breast Pathology biopsy report

303

0.82

0.39

1.4

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

456

1.14

0.39

1.6

9.15

14.15

u/ml

0.78

100

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

305

3196

0.94

0.39

3.3

0.87

0.80

ug/l

0.37

218

2153

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.43

0.39

1.0

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

0.00

0.39

0.0

1.3

—

29.85

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

0.00

0.39

0.0

1.0

—

17.25

—

(3026470) Cobalt [Mass/volume] in Blood

1.38

0.38

1.6

2.1

2.82

3.45

ug/l

0.33

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.39

0.38

1.0

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

215

1.21

0.38

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

206

1.22

0.38

2.1

2.8

3.59

24.86

u/ml

0.60

201

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.33

0.37

2.3

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

102

1105

0.92

0.34

1.5

1.4

—

(3011288) Drugs identified in Urine by Screen method Nominal

275

0.83

0.33

3.8

2.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

104

1122

0.92

0.32

1.7

2.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

192

1.20

0.32

1.8

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

192

1.20

0.32

1.8

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

119

1.26

0.31

1.0

1.1

305.00

287.12

mg/l

0.51

108

(3005988) Vibrio sp identified in Specimen by Organism specific culture

193

1.19

0.30

1.8

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

147

1.23

0.30

1.1

1.34

3.53

u/ml

—

(3020650) Glucose [Presence] in Urine

1.27

0.30

2.7

1.6

0.00

0.05

estimate

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

234

2238

1.05

0.29

1.3

17.38

11.77

u/ml

0.44

812

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.25

0.29

1.1

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

148

1.22

0.29

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

440

0.88

0.29

2.8

3.6

0.81

0.83

nmol/l

0.16

361

(40765096) Chromosome analysis panel by Banding

1.23

0.29

1.6

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.29

0.28

1.0

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.29

0.28

1.1

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.25

0.27

1.3

1.7

—

1631885.57

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.28

0.26

2.3

2.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

225

1.16

0.26

1.3

1.1

—

1.40

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.67

0.25

1.0

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

202

0.84

0.24

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

202

0.84

0.24

1.0

1.1

—

(3000492) Spirometry study

124

1310

0.94

0.24

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

610

1.09

0.24

2.4

3.3

406.10

2562.41

u/ml

0.71

526

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

190

0.84

0.23

1.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

171

1.17

0.23

1.1

0.73

1.83

u/ml

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.28

0.23

3.4

2.9

8.60

727.31

ug/l

—

(4015189) Microbial culture of sputum

1.28

0.23

2.2

2.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

172

1647

1.05

0.22

3.3

4.1

22.23

21.51

ug/l

0.02

138

1369

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

0.74

0.22

2.3

2.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

381

1.10

0.22

2.0

1.7

456.25

286.20

mu/l

1.08

345

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.14

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

5.45

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

7.5

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.00

0.21

0.0

1.0

—

0.06

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.13

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.21

0.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.21

0.0

1.4

—

6.22

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.25

0.20

2.7

1.4

10.50

7.43

ug/l

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.25

0.20

1.0

1.1

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

104

1095

0.95

0.19

1.6

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.18

0.19

1.2

1.5

—

(4281824) Cell count and differential, peritoneal fluid

143

0.84

0.18

1.8

1.2

—

(3045142) Bone marrow Pathology biopsy report

174

0.86

0.17

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

138

1.16

0.17

1.4

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

138

1.16

0.17

1.4

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

138

1.16

0.17

1.4

1.7

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

111

1.17

0.15

1.2

0.02

1.02

u/ml

—

(3044927) Protein electrophoresis panel - Urine

182

0.88

0.15

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.13

0.15

1.0

1.2

—

(36660697) Celiac disease serology panel - Serum

112

1076

1.04

0.15

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

165

1599

1.04

0.14

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1032

0.96

0.14

1.7

2.0

—

(1761868) Lipid panel - Serum or Plasma

482

4755

1.02

0.12

4.1

3.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

610

0.95

0.12

3.3

3.4

32.23

90.90

u/ml

1.97

590

(3003888) Timothy IgE Ab [Units/volume] in Serum

181

1.11

0.12

1.1

1.0

4.68

4.79

u/ml

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

900

0.96

0.10

1.2

—

(3044007) Cell count panel - Peritoneal fluid

1.11

0.09

4.8

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.09

0.09

1.2

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

340

1.06

0.09

1.3

1.5

17.23

9.19

u/l

1.10

274

(37208534) Antinuclear antibody arbitrary concentration in serum

1.04

0.09

1.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

126

1.11

0.09

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

627

1.04

0.08

1.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

117

1.11

0.08

1.3

1.2

—

(3002256) Pathology report gross observation

194

1906

1.02

0.08

1.3

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

215

1.07

0.07

1.1

0.53

2.06

u/ml

—

126

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.05

0.07

2.6

3.7

0.56

1.03

—

(40768795) Lymph node Pathology biopsy report

122

0.90

0.07

1.5

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

214

0.93

0.07

1.1

12.25

21.66

au/ml

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

430

4336

0.99

0.06

4.9

4.7

23.03

21.73

0.77

223

2208

(3024891) Influenza virus A+B Ag [Presence] in Specimen

385

0.96

0.05

1.1

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

151

1.06

0.03

1.5

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

359

0.97

0.02

1.2

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

176

0.97

0.00

3.5

3.6

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

175

1.03

0.00

1.1

0.27

1.65

u/ml

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1.01

0.00

2.1

1.5

1.62

1.17

promille

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.01

0.00

1.2

1.5

96.80

89.15

umol/l

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

221

1.00

0.00

1.3

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

555

1.01

0.00

1.7

1.6

0.26

0.35

mg/l

0.49

256

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

438

1.00

0.00

1.8

3.42

3.64

mg/l

0.10

344

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

348

1.01

0.00

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

198

1.01

0.00

2.2

2.4

28.89

22.97

mg/l

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

188

1.01

0.00

1.2

—

(3005570) Glucose [Moles/volume] in Urine

163

0.98

0.00

1.7

2.1

—

(3028707) Methadone [Presence] in Urine by Screen method

173

0.98

0.00

3.4

2.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

353

0.99

0.00

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

123

1233

1.00

0.00

2.0

2.4

12.28

12.86

nmol/l

0.30

106

1108

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.0

1.5

—

4.31

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.1

—

49.11

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.4

—

2.88

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.0

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.92

-0.00

1.0

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.00

-0.00

6.0

1.4

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

183.40

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

1.02

-0.00

1.8

1.4

17.06

13.54

g/l

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

-0.00

0.0

1.7

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.6

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(4038314) Semen analysis, post vasectomy

0.00

-0.00

0.0

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.6

—

2.26

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

0.97

-0.00

1.2

1.5

33.93

39.55

g/l

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

12.8

—

(3001556) Androgen free Index in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.05

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

359.17

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.1

—

7.69

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: H7_GLAUCSECDISEASE – Glaucoma secondary to other eye disorders

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Glaucoma secondary to other eye disorders

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Glaucoma secondary to other eye disorders (H7_GLAUCSECDISEASE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints